NIH Clinical Research Studies Listed By Protocol Number


Active Accrual, Protocols Recruiting New Patients 
* 08-NR-0132:
Evaluation and Diagnosis of Potential Research Subjects with Pain and Fatigue Syndromes

* 08-N-0212:
Intermittent Theta-Burst Transcranial Magnetic Stimulation (TBS) for the Treatment of Parkinson Disease

* 08-N-0198:
Warfighter Head Injury Study - a Comprehensive, Multidisciplinary Research Evaluation

* 08-N-0192:
Functional Neuro-Imaging of Strategy use During Human Behavior

* 08-N-0189:
The Relationship Between Temporal Discrimination and Cortical Excitability in Humans

* 08-N-0181:
Role of Neurotransmission and Functional CNS Networks in Spasmodic Dysphonia

* 08-N-0161:
Noninvasive Language Mapping in Patients with Localization-Related Epilepsy

* 08-N-0153:
The Role of Autoimmunity in Neurologic Complications of Celiac Disease

* 08-N-0134:
Pilot Study of Tolerability of Lithium Therapy in Patients with Spinocerebellar Ataxia Type I (SCA1)

* 08-N-0095:
Assessment of Cerebral Circulation and Perfusion in Adults after Neonatal Carotid Occlusion

* 08-N-0045:
Investigation of the Dopamine System in Frontotemporal Dementia

* 08-N-0044:
A Prospective Natural History Study of Patients with Neurofibromatosis Type 2 (NF2)

* 08-N-0040:
The Association Between Focal Dystonia (FD) and Complex Regional Pain Syndrome (CRPS)

* 08-N-0027:
HHV6B in Epilepsy Imaging and CSF Studies

* 08-N-0023:
Motor Cortex Reward Signaling in Parkinson Disease

* 08-N-0012:
L-Dihydroxyphenylserine (L-DOPS) for Norepinephrine Deficiency: Interactions with Carbidopa and Entacapone

* 08-M-0196:
Investigation of the Antidepressant Efficacy of a Selective, High Affinity Enkephalinergic Agonist in Anxious Major Depressive Disorder

* 08-M-0190:
Effects of Chronic Musculoskeletal Pain and Opioidergic versus Placebo Interventions on Neuroendocrine Function in Men

* 08-M-0158:
PET Imaging of Peripheral Benzodiazepine Receptors Using [11C](R)-PK 11195 and [11C]PBR28

* 08-M-0154:
An Investigation of the Relationship Between Donepezil Enhanced REM Sleep, Sleep Architecture and Behavior in the Prepubertal Child with Autism

* 08-M-0150:
An Investigation to Determine Whether Levels of P11 Protein in Peripheral Blood Cells Correlate with Treatment Response to Citalopram in Patients with Major Depressive Disorder

* 08-M-0124:
Measurement of P-glycoprotein Function in Alzheimer Disease, Parkinson Disease, and Frontotemporal Dementia Using Positron Emission Tomography

* 08-M-0066:
PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in Dementia

* 08-M-0062:
Brain and Whole Body Imaging of P-Glycoprotein Function using [11C]dLop

* 08-M-0052:
fMRI Investigation of Cortical Reorganization and Phantom Limb Pain Following Amputation

* 08-M-0049:
Imaging of Cannabinoid CB1 Receptors Using [18F]MePPEP-d2

* 08-M-0048:
PET Test/Retest Brain Imaging of Cannabinoid CB1 Receptors Using [11C]MePPEP

* 08-M-0006:
PET Imaging of Peripheral Benzodiazepine Receptors in Patients with Carotid Atherosclerosis

* 08-M-0002:
Randomized, Double-Blinded, Placebo Controlled Study of the Effects of Atomoxetine on Cognitive Function in Patients with Schizophrenia and Normal Controls Based on COMT Genotype

* 08-I-0209:
A Multicenter, Randomized Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Tolerability, and Efficacy of AVONEX in Subjects with Moderate to Severe Ulcerative Colitis

* 08-I-0201:
Pioglitazone for Hepatic Steatosis in HIV/HCV Co-infection

* 08-I-0184:
Studies in the Pathogenesis of Idiopathic Anaphylaxis

* 08-I-0174:
A Pilot Study of Therapy with Pioglitazone Prior to HCV Treatment in HIV-1 and HCV Genotype 1-Infected Subjects with Insulin Resistance Who Are Prior Nonresponders to Peginterferon and Ribavirin Therapy

* 08-I-0171:
A Phase I, Open Label, CT to Evaluate the Safety, Tolerability and Immunogenicity of a Multiclade Recombinant HIV-1 Adenoviral Vector Vaccine, VRC-HIVADV014-00-VP In Uninfected Adults Randomized to Needle or Biojector Methods of Intramuscular Injection

* 08-I-0093:
A Phase I Double-Blind, Placebo-Controlled, Dose-Escalating Study to Evaluate the Safety and Tolerability of Topical Nasal Poly-ICLC

* 08-I-0065:
VRC 206: A Phase I Study to Evaluate the Safety and Immunogenicity of an Ebola DNA Plasmid Vaccine, VRC-EBODNA023-00-VP, and a Marburg DNA Plasmid Vaccine, VRC-MARDNA025-00-VP, in Healthy Adults

* 08-I-0063:
A Phase III, Multicenter Placebo-Controlled, Randomized, Double-Blind Study to Evaluate Safety/Efficacy of PROCHYMALTM IV Infusion for Induction of Remission in Subjects Experiencing Tx of Refractory Moderate to Severe Crohn's Disease

* 08-I-0053:
Pilot (Phase I-II) Study of Valproic Acid (Depakote) for the Treatment of the Autoimmune Lymphoproliferative Syndrome (ALPS)

* 08-I-0034:
Validation of (1)H-Magnetic Resonance Spectroscopy for Quantification of Hepatic Triglyceride Content

* 08-HG-0122:
Patient-Provider Communication and Interaction in a Virtual Clinical Setting

* 08-HG-0059:
Studies of Skin Microflora in Healthy Individuals and Atopic Dermatitis Patients

* 08-H-0186:
Safety and the Anti- Tumor Effects of Escalating Doses of Adoptively Infused Ex Vivo Expanded Autologous Natural Killer (NK) Cells Against Metastatic Cancers or Hematological Malignancies Sensitized to NK -TRAIL Cytotoxicity with Bortezomib

* 08-H-0185:
Technical Development of Interventional Cardiovascular Magnetic Resonance Imaging in Normal Volunteers

* 08-H-0177:
Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus Trial (The MILES Trial)

* 08-H-0156:
Screening of Subjects to Determine Eligibility to Safely Participate in Blood Disorders Studies

* 08-H-0108:
Effects of Worksite Wellness Interventions on Vascular Function, Insulin Sensitivity and High-Density Lipoprotein in Overweight or Obese Women

* 08-H-0084:
Evaluation of Systemic Toxicity Associated with Allogeneic Peripheral Blood Stem Cell Infusion

* 08-H-0081:
Identification of Biomarkers in Exhaled Breath Condensates from Asthmatic Patients

* 08-H-0067:
Ciliary Dysfunction as an Underlying Etiology Linking Primary Ciliary Dyskinesia with Heterotaxy and Complex Congenital Heart Disease

* 08-H-0047:
A Randomized, Placebo-Controlled, Double-Blind Pilot Study of Pioglitazone Hydrochloride in Allergic Asthma

* 08-H-0046:
Co-Infusion of Umbilical Cord Blood and Haploidentical CD34+ Cells Following Nonmyeloablative Conditioning as Treatment for Severe Aplastic Anemia and MDS Associated with Severe Neutropenia Refractory to Immunosuppressive Therapy

* 08-H-0028:
Pilot Study of Monocyte Biology in Insulin Sensitive, Resistant and Diabetic Subjects

* 08-H-0016:
Effect of Fasting on the Size of Lymphangioleiomyomas in Patients with Lymphangioleiomyomatosis

* 08-EI-0175:
Pilot Study of the Evaluation of Sirolimus in the Treatment of Diabetic Macular Edema

* 08-EI-0169:
Evaluation and Treatment Protocol for Potential Research Participants with Ocular Diseases

* 08-EI-0147:
Pilot Study of Intravitreal Injection of Ranibizumab for Macular Telangiectasia without Neovascularization (MACTEL 2)

* 08-EI-0146:
Pilot Study of Intravitreal Injection of Ranibizumab for Macular Telangiectasia with Neovascularization (MACTEL 1)

* 08-EI-0135:
Pilot Validation Study of Computer Administration of Vision Targeted Quality of Life Instruments

* 08-EI-0129:
Pilot Study of Sunitinib Malate for Advanced Ocular Disease of Von Hippel-Lindau Syndrome

* 08-EI-0103:
High Speed Indocyanine Green Angiography Findings in Induction / PRN Regimen of Intravitreal Ranibizumab Injection for Neovascular Age-Related Macular Degeneration

* 08-EI-0102:
Screening Study for the Evaluation and Diagnosis of Potential Research Participants

* 08-EI-0099:
Epigenetics, Molecular Genetics, and Biomarkers of Degenerative and Inflammatory Ocular Diseases

* 08-EI-0061:
Pilot Study for the Detection of Neutralizing Antibodies in Patients treated with Bevacizumab (Avastin™ (Trademark)) or Ranibizumab (Lucentis™ (Trademark))

* 08-EI-0043:
Age-Related Eye Disease Study (AREDS) Follow-Up

* 08-EI-0031:
Visual Motor Coordination

* 08-EI-0017:
Evaluation and Treatment Protocol for Potential Research Participants with Inherited Ophthalmic Diseases

* 08-DK-0187:
Natural History and Pathophysiology of Gastrointestinal Graft Versus Host Disease

* 08-DK-0182:
Viral Kinetics and Liver Gene Expression in Response to Ribavirin and Peginterferon Therapy of Chronic Hepatitis C

* 08-DK-0173:
A Trial of Segmental Stiffening Wires to Improve the Efficiency and Patient Tolerability of Colonoscopy

* 08-DK-0165:
Thyroid Hormones Homeostasis and Energy Metabolism Changes During Stimulation of Endogenously Secreted Bile Acids (BAs)

* 08-DK-0157:
A Trial of Oral Nifedipine for the Treatment of Iron Overload

* 08-DK-0149:
High Dose Ribavirin in Combination with Peginterferon for Patients with Chronic Hepatitis C Genotype 1 Infection Who Have Failed to Respond or Relapsed After Standard Therapy

* 08-DK-0138:
A New Method for Determining Gastric Acid Output Using a Wireless Capsule

* 08-DK-0106:
Hepatitis C Eradication and Progression of Atherosclerosis

* 08-DK-0098:
Natural History of Familial Carcinoid Tumor

* 08-DK-0004:
High Throughput Screening of Compound Libraries to Discover a Drug for the Treatment of Sickle Cell Disease

* 08-D-0018:
Clinical and Laboratory Evaluation of the Autonomic Nervous System in Primary Sjogren's Syndrome

* 08-CH-0203:
A Pilot Study to Assess the Feasibility of PTH-1-34 Therapy via Pump in the Management of Chronic Hypoparathyroidism

* 08-CH-0170:
Establishment of a Fibroid Tissue Bank

* 08-CH-0139:
Preventing Excessive Weight Gain in Adolescent Girls at High-Risk for Adult Obesity

* 08-CH-0085:
Eating Behavior in Adolescents

* 08-CH-0022:
Treatment of Menorrhagia in Women with Aplastic Anemia: Platelet Transfusion Alone to Platelet Transfusion with Continuous Oral Contraceptive Pills

* 08-CH-0001:
Calibration of Non-Invasive Non-ionizing Imaging Techniques to Study Vasculature of Healthy Volunteers

* 08-CC-0205:
Evaluation of Assessments of Motor Performance, Physical Impairments and Functional Abilities

* 08-CC-0193:
Research Participant Perception of Care Project: Part 1: Focus Groups of Research Participants and Research Professionals to Identify Key Dimensions of the Research Participant Experience

* 08-CC-0133:
Response and Adaptation to Aerobic Exercise in Patients with Pulmonary Hypertension: Initial Studies for Establishing Guidelines

* 08-CC-0127:
Communicating a Cancer Diagnosis: Current Methods and Their Effects

* 08-CC-0032:
Parental Permission and Adolescent Assent and Decision Making in Clinical Research

* 08-C-0208:
Pilot Trial of Pioglitazone in Adults Undergoing Surgical Resection of Non-Small Cell Lung Cancer

* 08-C-0180:
Phase I Trial of the Raf Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib (BAY 43-9006, Nexavar) in Children and Young Adults with Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas

* 08-C-0179:
A Phase I Study of VEGF Trap (NSC #724770, IND #100137) in Children with Refractory Solid Tumors

* 08-C-0168:
A Phase II Trial of Sunitinib in the Treatment of Recurrent Malignant Gliomas

* 08-C-0166:
An Open Label Pilot Study to Evaluate the Effect on the Immune System of Talactoferrin in Adults with Non-Small Cell Lung Cancer (NSCLC)

* 08-C-0164:
A Phase II, Multicenter, Open-Label Trial Evaluating the Activity and Tolerability of Romidepsin (Depsipeptide, FK228) in Progressive or Relapsed Peripheral T-cell Lymphoma Following Prior Systemic Therapy

* 08-C-0162:
Transfer of Autologous T Cells Transduced with the Anti-MART-1 F5 T Cell Receptor in High Risk Melanoma

* 08-C-0155:
Phase II Study of Metastatic Cancer that Overexpresses p53 Using Lymphodepleting Conditioning Followed by Infusion of Anti-p53 TCR-Gene Engineered Lymphocytes and Dendritic Cell Vaccination

* 08-C-0151:
A Pilot Study of Sirolimus (Rapamycin, Rapammune[Registered Trademark]) in Subjects with Cowden Syndrome or Other Syndromes Characterized by Germline Mutations in PTEN

* 08-C-0130:
A Phase II Trial of Peginterferon Alpha-2b (Pegintron) for Neurofibromatosis Type 1 Related Unresectable, Symptomatic or Life-Threatening Plexiform Neurofibromas

* 08-C-0128:
A Phase I Combination Study of AZD2281 and Cisplatin Plus Gemcitabine in Adults With Solid Tumors

* 08-C-0123:
A Phase 1, Single Center, Dose Escalation Study of CAT-8015 in Children, Adolescents, and Young Adults with Refractory CD22+ Acute Lymphoblastic Leukemia (pALL) or Non-Hodgkin's Lymphoma (NHL)

* 08-C-0121:
Phase II Study of Metastatic Cancer that Expresses NY-ESO-1 Using Lymphodepleting Conditioning Followed by Infusion of Anti-NY ESO-1 TCR-Gene Engineered Lymphocytes

* 08-C-0105:
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL) and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

* 08-C-0104:
Phase II Study in Patients with Metastatic Melanoma Using a Non-Myeloablative Lymphocyte Depleting Regimen of Chemotherapy Followed by Infusion of gp100 Reactive Peripheral Blood Lymphocytes (PBL) and High or Low Dose Aldesleukin

* 08-C-0101:
A Phase 2 Trial of Tandutinib in Combination with Bevacizumab for Patients with Recurrent High-Grade Gliomas

* 08-C-0097:
Multi-Institutional Prospective Phase II Study of Montelukast for the Treatment of Bronchiolitis Obliterans Following Allogeneic Stem Cell Transplantation in Children and Adults

* 08-C-0096:
A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas

* 08-C-0092:
A Phase I Study with an Expansion Cohort of the PARP Inhibitor AZD2281 (KU-0059436) Combined with Carboplatin in Breast and Ovarian Cancer in BRCA1/2 Mutation Carriers and Familial Breast and Ovarian Cancer

* 08-C-0091:
Phase I Study of SNX-5422 Mesylate in Adults with Refractory Solid Tumor Malignancies and Lymphomas

* 08-C-0088:
Low Intensity Allogeneic Hematopietic Stem Cell Transplantation Therapy of Metastatic Renal Cell Carcinoma Using Early and Multiple Donor Lymphocyte Infusions Consisting of Sirolimus-Generated Donor Th2 Cells

* 08-C-0087:
Phase I Study of Vandetanib (ZD 6474) and Bevacizumab Combination Therapy Evaluating the VEGF and EGF Signal Transduction Pathways in Adults with Solid Tumors and Lymphomas

* 08-C-0086:
A Phase 2, Open-Label, Two Arm Trial to Evaluate the Efficacy of PF-00299804 in Patients with Advanced NSCLC After Failure of at Least One Prior Chemotherapy Regime and Failure of Prior Treatment with Erlotinib

* 08-C-0083:
Registration Ph III Study of Lucanix ™ (Trademark) in Adv NSC Lung Cancer: An Intl Mltctr RDBPC Study of Lucanix™ (Trademark) Maint Ther for Stages III/IV NSCLC Subjects Who Have Responded to or Have Stable Dx Following One Reg of Front-line, P

* 08-C-0080:
SARC Global Collaboration: A Phase II Trial of R1507, a Recombinant Human Monoclonal Antibody to the IGF-1 Receptor for the Treatment of Patients with Recurrent or Refractory Ewing's Sarcoma, Synovial Sarcoma, Rhabdomyosarcoma and Other Sarcomas

* 08-C-0079:
Natural History Study and Longitudinal Assessment of Children, Adolescents, and Adults with Neurofibromatosis Type 1

* 08-C-0078:
A Phase I/II trial of Pemetrexed (Alimta [Registered Trademark]) Combined with Sirolimus (Rapamycin, Rapamune [Registered Trademark]) in Subjects with Relapsed or Refractory NSCLC Whose Tumors Bear Activation of mTOR

* 08-C-0077:
A Phase I, Multi-Institutional, Open-Label, Dose-Escalation, Multiple Dose Study of the Safety, Tolerability, and Immune Response of CRS-207 in Adult Subjects with Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates For Standard Tx

* 08-C-0075:
Phase III Evaluation of Recombinant MAGE-A3 Vaccine as Adjuvant Therapy Following Resection of MAGE-A3-Positive Non-Small Cell Lung Cancer

* 08-C-0074:
A Phase II Study of Satraplatin and Prednisone in Metastatic Androgen Independent Prostate Cancer (AIPC)

* 08-C-0071:
Phase I Study of Bortezomib and Cetuximab without or with Cisplatin in Combination with Radiation Therapy for Advanced Head and Neck Cancer

* 08-C-0051:
A Pilot Trial of WT1 Peptide-Loaded Allogeneic Dendritic Cell Vaccine and Donor Lymphocyte Infusion for WT1-Expressing Hematologic Malignancies

* 08-C-0039:
A Phase II Study of ZD6474 (Vandetanib) in Subjects with Advanced Clear Cell Renal Carcinoma

* 08-C-0035:
A Pharmacodynamic Study of the P-glycoprotein (Pgp) Antagonist, CBT-1® (Registered Trademark), Evaluating Pgp Inhibition in Tumors and Normal Tissues

* 08-C-0033:
Multicenter Phase II Study of Belinostat (PXD-101) in Previously Chemotherapy Treated Thymoma and Thymic Carcinoma

* 08-C-0030:
Phase I Trial of Fenretinide (4-HPR, NSC 374551) Lym-X-Sorb (LXS) Oral Powder (4-HPR/LXS Oral Powder) (4-HPR) in Adults With Solid Tumors and Lymphomas

* 08-C-0026:
A Phase 1, Single Center, Dose-Escalation Study of SS1(dsFv)PE38 Administered Concurrently with Pemetrexed and Cisplatin in Subjects with Unresectable Malignant Epithelial Pleural Mesothelioma

* 08-C-0020:
A Phase 2 Study of ZD6474 (Vandetanib) in Patients with Von Hippel Lindau Disease and Renal Tumors

* 08-C-0015:
A Phase II Trial of Enzastaurin (LY317615) in Combination with Bevacizumab in Adults with Recurrent Malignant Gliomas

* 08-C-0010:
Multiple Ascending Dose (MAD) Phase I Study of the IGF-1R Antagonist R1507 Administered as an Intravenous Infusion in Children and Adolescents with Advanced Solid Tumors

* 08-C-0007:
A Phase I Study of Ipilimumab (Anti-CTLA-4) in Children, Adolescents, and Young Adults with Treatment Refractory Cancer

* 08-AR-0029:
Phase Ib, MultiCenter Randomized, Double-Blind Placebo-Controlled, Dose Escalation Study w/Open-Label Extension to Evaluate Safety and Tolerability of Multiple IV Doses of MEDI-545; A Fully Human Anti-IFN-alpha Monoclonal Antibody in Patients w/SLE

* 08-AA-0178:
Computer-Assisted Self-Administration of Ethanol (CASE) in Humans

* 08-AA-0137:
A Randomized, Double-blind, Placebo Controlled Trial (RCT) of Varenicline to Reduce Alcohol Consumption in Heavy Drinkers

* 08-AA-0125:
Effect of Naltrexone on Craving and Ethanol-Induced Brain Activity

* 08-AA-0058:
Modulation of Pharmacologically Induced Alcohol Craving in Recently Detoxified Alcoholics

* 07-N-0191:
Role of the Cortical Medial Frontal Areas in Blepharospasm

* 07-N-0190:
Neurobiological Studies of Psychogenic Movement Disorders and Non-Epileptic Seizures

* 07-N-0187:
Brain Connectivity and Sensorimotor Integration During Single/Dual Motor Tasks

* 07-N-0165:
Suppression and Facilitation of the Motor Cortex by Stimulation of the Cerebellum in Patients with Dystonia and Healthy Controls

* 07-N-0156:
Biomechanics of Human Epiglottal Movement and Inversion

* 07-N-0154:
Influence of Lesion Location on Cortical Reorganization after Chronic Stroke

* 07-N-0147:
Effect of Direct Current Brain Polarization on Verbal Memory

* 07-N-0137:
Expanding the Phenotype of the LRRK-2 Mutation in Individuals with History of Parkinson's Disease and their Relatives: a Prospective Study

* 07-N-0122:
Modulation of Motor Function by Stimulation of the Central and Peripheral Nervous System

* 07-N-0103:
Imaging Serotoninergic Neurotransmission in Epilepsy

* 07-N-0092:
PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [(11)C]PBR28 in Patients with Multiple Sclerosis (MS)

* 07-N-0088:
The Characteristics of Sequence Effect in de novo and Advanced Parkinson's Disease

* 07-N-0072:
Neural Substrates of Lasting Motor Skill Learning by Spacing Effect

* 07-N-0066:
Direct Current Brain Polarization of Bilateral Prefrontal Cortex

* 07-N-0063:
Detecting a Reward Signal in the Motor Cortex

* 07-N-0050:
MRI of Alzheimer's Disease Imaging Amyloid Plaques in Persons With and Without Memory Problems

* 07-N-0022:
Enhancing Interhemispheric Disinhibition Between Motor Cortices Using Bilateral Brain Stimulation

* 07-N-0020:
Evaluation of the Plasticity of the Primary Motor Cortex and Motor Learning in Parkinson's Disease

* 07-N-0014:
The Use of Magnetic Resonance Imaging to Investigate Cortical Damage in Patients with Multiple Sclerosis and Correlation with Cognitive Dysfunction

* 07-M-0209:
PET Imaging of Peripheral Benzodiazepine Receptors in Patients with Neurocysticercosis Using [F-18]FBR

* 07-M-0208:
PET Imaging of Peripheral Benzodiazepine Receptors in Patients with Neurocysticercosis Using [C-11]PBR28

* 07-M-0201:
An Investigation of the Efficacy of the Glutamate Transporter GLT 1 in the Treatment of Bipolar Depression

* 07-M-0152:
An Investigation of the Antidepressant Effects of the Selective NR2B Antagonist MK-0657 in Major Depression

* 07-M-0127:
Functional Neuroanatomy of Emotion Perception, Recognition, Learning, and Memory

* 07-M-0082:
PET Imaging of Brain mGluR5 Receptors Using [18F]SP203

* 07-M-0036:
PET Imaging of Brain Amyloid Using [11C]MeS-IMPY

* 07-M-0024:
Treatment of Childhood Regressive Autism with Minocycline: an Anti-Inflammatory Agent Active within the CNS

* 07-M-0021:
Development of Functional and Structural Magnetic Resonance Imaging Techniques for the Study of Mood and Anxiety Disorders

* 07-I-0229:
Influenza in the Immunocompromised Host

* 07-I-0218:
A Double-Blind, Randomized, Placebo-Controlled Cross-Over Study Assessing the Role of Pathogen-Specific IgE and Histamine Release in the Hyper-IgE Syndrome and the Effect of Ranitidine on Laboratory and Clinical Manifestations

* 07-I-0205:
An Observational Study of the Immunopathogenesis of and Response to Step-Up Inflammatory Bowel Disease Therapy for Hermansky-Pudlak Syndrome-Associated Colitis

* 07-I-0183:
The Collection of Research Samples and/or Data for Repository from Related or Unrelated Hematopoietic Stem Cell Transplantation Recipients for the National Marrow Donor Program

* 07-I-0171:
Treatment for Growth Failure in Patients with X-Linked Severe Combined Immunodeficiency (XSCID): A Phase 2 Study Assessing Safety and Clinical Response to Treatment with Insulin-like Growth Factor-1 (IGF-1)

* 07-I-0167:
VRC 012: A Phase I Clinical Trial of the Safety and Immunogenicity of an HIV-1 Adenoviral Vector Serotype 35 Vaccine: Dose Escalation as a Single Agent and Prime-Boost Schedules with an HIV-1 Adenoviral Vector Serotype 5 Vaccine in Uninfected Adults

* 07-I-0142:
Research Respiratory Tract Procedures in Healthy Adult Volunteers and Adult Patients to Obtain Specimens for In Vitro Analyses of Infection Pathogenesis and Susceptibility

* 07-I-0105:
Pioglitazone for Hepatic Steatosis in HIV

* 07-I-0094:
Accuracy of Hemoglobin A1C to Predict Glycemia in HIV

* 07-I-0075:
Allogeneic and Matched Unrelated Donor Stem Cell Transplantation for Congenital Immunodeficiencies: Busulfan-based Conditioning with Campath- 1H or h-ATG, Radiation, and Sirolimus

* 07-I-0033:
Screening Protocol for Detection and Characterization of Infections and Infection Susceptibility

* 07-I-0017:
Autologous Transplantation of Genetically Modified Cells for the Treatment of X-Linked Chronic Granulomatous Disease

* 07-I-0001:
An Open Label Non-Randomized Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks with Ribavirin among HIV/HCV Coinfected Individuals

* 07-HG-0132:
Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome

* 07-HG-0076:
A Phase One Treatment Trial of the Circadian Sleep Disturbance in Smith-Magenis Syndrome (SMS)

* 07-HG-0002:
ClinSeq: A Large-Scale Medical Sequencing Clinical Research Pilot Study

* 07-H-0225:
A Pilot Study of the Safety and Activity of Escalating Doses of ON 01910.Na in Patients with RAEB-1 AND RAEB-2 Myelodysplastic Syndrome (MDS) and AML with Trisomy 8

* 07-H-0196:
Niacin Therapy to Improve Endothelial Function in Sickle Cell Disease

* 07-H-0177:
Treatment of Pulmonary Hypertension and Sickle Cell Disease with Sildenafil Therapy

* 07-H-0159:
Efficacy of WT1 and PRI Peptide Vaccination for Patients with Low Risk Myeloid Malignancies

* 07-H-0136:
Selective Depletion of Alloreacting T Cells Using a Photodepletion Technique to Prevent GVHD after HLA-Matched Peripheral Blood Stem Cell Transplantation for Subjects with Hematologic Malignancies

* 07-H-0128:
Gadofosveset Imaging of Chronic Total Peripheral Artery Occlusion (CTO)

* 07-H-0113:
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples from Normal Volunteers

* 07-H-0104:
A Phase II Study of Lenalidomide Revlimid® (Registered Trademark) in Previously Treated Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

* 07-H-0091:
WTI Peptide Vaccination for Patients with High Risk Hematological Malignancies

* 07-H-0056:
Validation of Cardiac MR Perfusion with Cardiac Catheterization Physiological Assessment

* 07-H-0055:
Effects of Interleukin-1 Inhibition on C-Reactive Protein Levels, Endothelial Progenitor Cell Mobilization and Endothelial Function in Patients with Coronary Artery Disease

* 07-H-0030:
Metabolic Regulation by Tumor Suppressor p53 in Li-Fraumeni Syndrome

* 07-H-0005:
Pilot Study of Topical Dexamethasone 0.01% Solution for Prevention of Oral Chronic Graft Versus Host Disease

* 07-EI-0145:
Ocular Impact of X Chromosome Karyotype and Sex Hormones in Turner Syndrome and Premature Ovarian Failure

* 07-EI-0025:
The Age-Related Eye Disease Study 2 (AREDS2): A Multi-Center, Randomized Trial of Lutein, Zeaxanthin, and Omega-3 Long-Chain Polyunsaturated Fatty Acids (Docosahexaenoic Acid [DHA] and Eicosapentaenoic Acid [EPA]) in Age-Related Macular Degeneration

* 07-E-0012:
Rituximab in the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)

* 07-DK-0219:
A Nutrigenomics Intervention for the Study of the Role of Dietary Sitosterol on Lipid, Glucose and Energy Metabolism

* 07-DK-0212:
Prospective Evaluation of Albuminuria in HIV Positive Patients

* 07-DK-0207:
Tenofovir Disoproxil Fumarate Alone Versus its Combination with Emtricitabine for Treatment of Chronic Hepatitis B

* 07-DK-0202:
Thyroid Hormones Homeostasis and Energy Metabolism Changes During Exposure to Cold Temperature in Humans

* 07-DK-0163:
The Effect of Diet on Vascular Disease: A Study of Pre-Menopausal African Amercian and Caucasian Women

* 07-DK-0143:
Effects of S-Adenosyl Methionine (SAMe) on Viral and Cell Signaling Response to Combination Therapy for Chronic Hepatitis C

* 07-DK-0115:
Effect of Short-Term Beta-Cell Rest in Adolescents and Young Adults with Type 2 Diabetes Mellitus

* 07-DK-0077:
Study of the Phenotype of Overweight and Obese Adults

* 07-CH-0211:
A Phase 2, Open Label, Crossover Pharmacokinetic and Pharmacodynamic Study to Compare Chronocort Versus Cortef in Patients with CAH

* 07-CH-0192:
Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors

* 07-CH-0126:
Pilot Study of the Metabolic Effects of Betahistine Hydrochloride (Obecure) in Overweight Women

* 07-CH-0008:
Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion

* 07-CC-0153:
Effects of Peripheral Blood Stem Cell Transplantation on the Microbial Flora of the Oral Cavity

* 07-CC-0125:
Pilot Study of the Incidence of HLA Class I and Class II Antibodies in Platelet Donors and their Effects on the Transfusion Recipient

* 07-CC-0090:
Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders

* 07-CC-0067:
A Feasibility Study to Test an Individualized Dyadic Problem-Solving Education Intervention to Improve Problem-Solving Skills of Patients and Family Caregivers During Allogeneic HSCT

* 07-CC-0011:
Hypnosis as a Pain and Symptom Management Strategy in Patients with Sickle Cell Disease

* 07-C-0230:
A Phase II Study of Hypofractionated Highly Conformal Radiation With Helical Tomotherapy for Extra-Cranial Oligometastases

* 07-C-0228:
Phase I and Pharmacokinetic Study of Vorinostat for Solid Tumors and Lymphomas in Patients with Varying Degrees of Hepatic Dysfunction

* 07-C-0222:
Pilot Trial of the NK1 Receptor Radio-Ligand [18F]SPA-RQ: Imaging Pancreatic Ductal Adenocarcinoma

* 07-C-0220:
A Phase I Study of Sunitinib (SU11248), an Oral Multi-Targeted Tyrosine Kinase Inhibitor, in Children With Refractory Solid Tumors

* 07-C-0210:
Phase I/II Study Using a Non-Myeloablative Lymphocyte Depleting Regimen of Chemotherapy Followed by Infusion of Allogeneic Tumor-Reactive Lymphocyte Cell Line DMF5 in Metastatic Melanoma

* 07-C-0206:
A Pilot Study of Tumor Vaccination in Patients with High Risk Pediatric Solid Tumors and Altered T Cell Homeostasis

* 07-C-0203:
A Phase I Study of ABT-888 in Combination with Topotecan Hydrochloride in Adults with Refractory Solid Tumors and Lymphomas

* 07-C-0200:
A Phase 1, Multicenter, Dose-Escalation Study of CAT-8015 in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

* 07-C-0195:
Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation Using HLA-Matched Unrelated Donors and Utilizing Two Graft-Versus-Host Disease Prophylaxis Regimens

* 07-C-0189:
Phase I/II Trial of Vandetanib (ZD6474, ZACTIMA) in Children and Adolescents with Hereditary Medullary Thyroid Carcinoma

* 07-C-0188:
A Double-Blind Randomized Phase 2.5 Trial of ONY-P1 Vaccine Versus Placebo in Men with D0 Prostate Cancer Following Limited Androgen Ablation

* 07-C-0176:
A Phase II Study Using Short-Term Cultured Anti-Tumor Autologous Lymphocytes Following a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen in Metastatic Melanoma

* 07-C-0175:
Phase II Study of Metastatic Melanoma Using Lymphodepleting Conditioning Followed by Infusion of Anti-MART-1 F5 TCR-Gene Engineered Lymphocytes

* 07-C-0174:
Phase II Study of Metastatic Melanoma Using Lymphodepleting Conditioning Followed by Infusion of Anti-gp100:154-162 TCR-Gene Engineered Lymphocytes

* 07-C-0166:
A Phase I Study of BMS-354825 (DASATINIB) in Children with Recurrent/Refractory Solid Tumors or Imatinib Resistent PH Plus Leukemia

* 07-C-0134:
A Phase II Study of Combination Oral CC-5013 Lenalidomide (Revlimid ® (Registered Trademark)), Oral Sunitinib (Sutent) and Low Dose Oral Metronomic Cyclophosphamide for the Treatment of Stage IV Ocular Melanoma

* 07-C-0133:
Phase I Study of Topical Romidepsin (Depsipeptide) in Early Stage Cutaneous T-Cell Lymphoma

* 07-C-0130:
A Phase 1, Multicenter, Dose-Escalation Study of CAT-8015 in Patients with Relapsed or Refractory Hairy Cell Leukemia (HCL)

* 07-C-0123:
Pilot Trial to Identify and Characterize Breast Stem Cells in Women at Average Risk and Increased Risk for Breast Cancer

* 07-C-0121:
A Phase 2 Study of the c-Met RTK Inhibitor GSK1363089 (Formerly XL880) in Subjects with Papillary Renal-Cell Carcinoma (PRC)

* 07-C-0114:
A Phase I Study of Subcutaneous CYT 107 (Interleukin-7) in Refractory Metastatic Melanoma or Renal Cell Carcinoma

* 07-C-0111:
A Pilot Study of Markers of Tumor Burden and Radiation Toxicity in the Blood, Urine, and Stool of Patients Receiving Radiotherapy for Gastrointestinal Malignancies

* 07-C-0110:
Analysis of Stored Data Collected from Individuals Administered Neurobehavioral Assessments on IRB-Approved Protocols

* 07-C-0108:
A Phase 1, Multicenter, Dose Escalation Study of CAT-8015 in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL), Prolymphocytic Leukemia (PLL), or Small Lymphocytic Lymphoma (SLL)

* 07-C-0107:
A Randomized Phase II Trial Combining Vaccine Therapy with PROSTVAC/TRICOM and Flutamide vs. Flutamide Alone in Men with Androgen Insensitive, Non Metastatic (D0.5) Prostate Cancer

* 07-C-0106:
A Randomized Phase 2.5 Study of (153)Sm-EDTMP (Quadramet) With or Without a PSA/TRICOM Vaccine in Men With Androgen-Insensitive Metastatic Prostate Cancer

* 07-C-0101:
A Phase 0 Trial of (111)Indium CHX-A" DTPA trastuzumab Imaging in Cancer

* 07-C-0100:
Collection of Blood from Patients with Prostate Cancer

* 07-C-0097:
A Phase I Study of Batracylin (NSC320846) in Subjects with Solid Tumors and Lymphomas

* 07-C-0087:
A Natural History Study of HIV Acquired in Infancy or Childhood

* 07-C-0086:
Pilot Study of Educational Interventions in Pediatric Hematopoietic Stem Cell Donors to Increase Knowledge of Donation and Transplantation Procedures

* 07-C-0085:
An Exploratory Study of the Use of Five Wishes as a Tool for Advanced Care Planning in Young Adults with Metastatic, Recurrent, or Progressive Cancer or HIV Disease

* 07-C-0081:
A Phase I/II Study of Flavopiridol in Relapsed or Refractory Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell Lymphoma (DLBCL)

* 07-C-0074:
A Phase II Study of ABT-751, an Orally Bioavailable Tubulin Binding Agent, in Children with Relapsed or Refractory Neuroblastoma

* 07-C-0064:
Adoptive Cell Therapy for B-Cell Malignancies After Allogeneic Hematopoietic Stem Cell Transplantation with Costimulated, Tumor-Derived Lymphocytes

* 07-C-0061:
Phase II Study of Clinical Activity and Proteomic Pathway Profiling of the VEGFR2 Inhibitor, Vandetanib in Women With Relapsed or Refractory Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

* 07-C-0060:
Prospective Evaluation of Tumor Angiogenesis in Endocrine Neoplasms

* 07-C-0059:
A Phase II Study of AZD2171 in Metastatic Androgen Independent Prostate Cancer

* 07-C-0058:
A Phase II Study of Sorafenib and Bevacizumab in Epithelial Ovarian, Fallopian, and Peritoneal Cancer

* 07-C-0054:
A Phase I Trial and Pharmacokinetic Study of Trabectedin (YONDELIS [R], ET-743) in Children and Adolescents with Relapsed or Refractory Solid Tumors

* 07-C-0053:
A Phase I Trial of Enzastaurin (LY317615) in Combination with Carboplatin in Adults with Recurrent Gliomas

* 07-C-0052:
A Phase 2 Study of O6-Benzylguanine (O(6)-BG) and Temozolomide in Patients with Glioblastoma Progressing at Least 3 Months After Completion of Primary Treatment with Radiation Therapy and Temozolomide

* 07-C-0047:
A Phase I Trial of Nelfinavir (Viracept) in Adults with Solid Tumors

* 07-C-0043:
An Evaluation of the Tissue Distribution and the Selective Tumor Trafficking of TNF-Bound Colloidal Gold (CYT-6091) Following Intravenous Administration in Subjects with Primary and Metastatic Cancer Undergoing Surgical Resection

* 07-C-0040:
A Phase I Trial of Monoclonal Antibody HGS-ETR2 (Lexatumumab) in Patients with Refractory Pediatric Solid Tumors

* 07-C-0006:
A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics and Efficacy of ABT-263 in Subjects with Relapsed or Refractory Lymphoid Malignancies

* 07-C-0003:
Phase II Study of Metastatic Cancer that Overexpresses p53 Using Lymphodepleting Conditioning Followed by Infusion of Anti-p53 TCR-Gene Engineered Lymphocytes

* 07-AT-0089:
An Exploratory Study to Evaluate the Ability of Epigallocatechin Gallate to Simultaneously Improve Metabolic and Cardiovascular Actions of Insulin in Healthy, Obese, Hypertensive, or Diabetic Subjects

* 07-AA-0026:
OPRM1 A118G SNP, Alcohol Response, and Striatal Dopamine

* 06-NR-0229:
Neurotropin Treatment of Fibromyalgia

* 06-N-0243:
Brain Connectivity Between Visual Input and Motor Output

* 06-N-0242:
The Effect of Surround Inhibition During Phasic Compared to Tonic Voluntary Finger Movement in Focal Hand Dystonia

* 06-N-0232:
Hypersensitivity in Tourette Syndrome: An Evaluation of Perceived Intensity Versus Threshold

* 06-N-0225:
Influencing Motor Performance in Patients with Stroke by Combined Theta Burst Stimulation and Carbidopa-Levodopa

* 06-N-0224:
Collection of Blood Samples for DNA Analysis in Motor Neuron Diseases

* 06-N-0212:
A Comparison of an Implanted Neuroprosthesis with Sensory Training for Improving Airway Protection in Chronic Dysphagia

* 06-N-0209:
Plasma Exchange for Autoimmune Autonomic Failure

* 06-N-0192:
Blepharospasm and the Experimental Modulation of Cortical Excitability in Primary and Secondary Motor Areas. A Pilot Study.

* 06-N-0187:
Anticonvulsive Effects of Transcranial DC Stimulation in Pharmacoresistant Focal Epilepsy

* 06-N-0174:
Cortical Function in Primary Lateral Sclerosis and Amyotrophic Lateral Sclerosis

* 06-N-0161:
Long-Term Motor Learning in Focal Hand Dystonia

* 06-N-0154:
An Exploratory Study on Detection of Cortical and White Matter Damage in Patients with Multiple Sclerosis Using Magnetic Resonance Imaging at 7 Tesla

* 06-N-0138:
Long-Term Improvement in Training Effects by Transcranial DC Stimulation

* 06-N-0128:
fMRI Studies of Task Specificity in Focal Hand Dystonia

* 06-N-0126:
Neurophysiology of Task-Specificity of Focal Hand Dystonia

* 06-N-0125:
Physiology of Weakness with Movement Disorders

* 06-N-0120:
Induction of Volitional Swallowing in Chronic Dysphagia Post Stroke: A Novel Mechanism-Based Intervention

* 06-N-0095:
Contribution of Interhemispheric Inhibition to Motor Learning

* 06-N-0085:
Two-Compartment Model of Diffusion Tensor Magnetic Resonance Imaging (DT-MRI) for the Diagnosis of Glioma Tumor Recurrence versus Radiation Necrosis

* 06-N-0084:
Brain Networks Responsible for Sense of Agency: An EEG Study

* 06-N-0080:
Implicit Tactile Learning in Chronic Stroke Enhanced by Non-Invasive Brain Stimulation of the Somatosensory Cortex

* 06-N-0048:
Changes in Activation Patterns in the Ventro-Medial Prefrontal Cortex of Healthy Adolescents During the Imagination and Observation of Aggressive Behavior

* 06-N-0047:
Reference Values for Plasma Catechols

* 06-N-0031:
Evaluation of Density and Pattern of Distribution of GABA A Receptors in the Brain of Patients with Focal Hand Dystonia Studied with PET using [11C] Flumazenil

* 06-N-0027:
Neuropsychiatric Correlates of Psychogenic Movement Disorder and Non-Epileptic Seizure

* 06-N-0023:
Brain Networks Responsible for Self-Agency: An fMRI study

* 06-N-0022:
PET Imaging of GABA Receptors in Succinic Semialdehyde Dehydrogenase Deficiency

* 06-N-0012:
Moving a Paralyzed Hand Through a Brain-Computer Interface Controlled by the Affected Hemisphere After Stroke

* 06-M-0253:
Evaluation of the Efficacy of the NK1 Antagonist GR205171 in Posttraumatic Stress Disorder

* 06-M-0246:
PET Scanning of Brain Dopaminergic Signal Transduction Involving Arachidonic Acid in Adults with Attention Deficit Hyperactivity Disorder (ADHD)

* 06-M-0234:
The Antidepressant Efficacy of the Anticholinergic Scopolamine

* 06-M-0215:
Antidepressant Effects on cAMP Specific Phosphodiesterase (PDE 4) in Depressed Patients

* 06-M-0214:
PET Measurement of Regional Rates of Cerebral Protein Synthesis in Subjects with Fragile X Syndrome

* 06-M-0162:
An Investigation Examining the Evidence for Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar Disorder

* 06-M-0155:
Identifying the Role of Oxytocin and Vasopressin in the Functioning of Neurocognitive Systems Involved in Mood Disorders

* 06-M-0102:
Clinical and Immunological Investigations of Subtypes of Autism

* 06-M-0065:
The Evaluation of Patients with Autism Spectrum Disorders and Healthy Volunteers

* 06-M-0002:
PET Whole Body Biodistribution and Test Retest Brain Imaging Studies Using a Phosphodiesterase 4 Inhibitor (R)-[11C]rolipram

* 06-I-0237:
A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Recombinant Ebola Adenoviral Vector Vaccine, VRC-EBOADV018-00-VP, in Healthy Adults

* 06-I-0235:
A Phase II Vaccine Dose Finding Pilot Study for Development of an Anti-Influenza A (H5N1) Intravenous Hyper-Immune Globulin

* 06-I-0217:
Genetic Disorders of Mucociliary Clearance

* 06-I-0207:
Investigation of Southern Tick-Associated Rash Illness (STARI)

* 06-I-0197:
A Randomized Placebo Controlled Trial of Atorvastatin in HIV Positive Patients Not on Antiretroviral Medications with the Specific Aims of Studying the Effects of Atorvastatin on HIV Viral Load and Immune Activation Markers

* 06-I-0160:
Infliximab Treatment for Crohn's-like Inflammatory Bowel Disease in Chronic Granulomatous Disease: A Phase I/II Study Assessing Clinical and Immune Responses to Treatment and Genetic Influences

* 06-I-0106:
High Dose Versus Standard-Dose Oseltamivir for the Treatment of Severe Influenza and Avian Influenza: A Phase II Double-Blind, Randomized Clinical Trial

* 06-I-0086:
A Cohort Observational Study Evaluating Predictors, Incidence and Immunopathogenesis of Immune Reconstitution Syndrome (IRIS) in HIV-1 Infected Patients with CD4 Count Less Than or Equal to 100 Cells/micro L Who Are Initiating Antiretroviral Therapy

* 06-I-0077:
Voriconazole Plasma Concentration and Toxicity

* 06-I-0074:
Collection of Blood from Persons with Hemoglobin and Erythrocyte Polymorphisms for Laboratory Malaria Research

* 06-I-0049:
Studies of Disorders in Antibody Production and Related Primary Immunodeficiency States

* 06-I-0032:
Pilot Study of Omalizumab (Xolair) in Hyper IgE (Job's) Syndrome

* 06-I-0030:
Correlation of the Precursor Frequency of CD4 + Effector Memory T Cells with Induration Measured in the Tuberculin Skin Test (TST)

* 06-I-0015:
Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death

* 06-I-0005:
Evaluation of Risk Factors for Development of Epstein-Barr Virus Lymphoproliferative Disease

* 06-HG-0134:
Natural History and Biology of Dermal Neurofibromas in Neurofibromatosis Type 1

* 06-HG-0055:
Functional Imaging in Subjects with Glucocerebrosidase Mutations

* 06-H-0249:
Magnetic Resonance Angiography (MRA) in the Diagnosis of Atherosclerotic Disease Using High Field (3T) MRI Scanners: A Pilot Technical Development Study

* 06-H-0248:
Peripheral Blood Stem Cell Allotransplantation for Hematological Malignancies Using a Positive Stem Cell Selection Technique for T Cell Depletion, Followed by Delayed T Cell Add-Back

* 06-H-0228:
A Pilot Study of Fractionated Dose Subcutaneous Rituximab (RTX, Rituxan® (Registered Trademark)) in Patients with Refractory or Relapsed Chronic Lymphocytic Leukemia

* 06-H-0222:
Role of Helicobacter Pylori and Its Toxins in Pulmonary and Oropharyngeal Disease

* 06-H-0203:
Catheter-Based Treatment of Cardiovascular Disease in Patients

* 06-H-0202:
Cardiopulmonary Function Assessment and NO Based Therapies for Patients with Hemolysis-Associated Pulmonary Hypertension

* 06-H-0190:
Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders with Alemtuzumab (Campath)

* 06-H-0165:
Evaluation of Endothelial and Hemodynamic Function in HIV Associated Pulmonary Hypertension and a Phase I/II Safety and Efficacy Trial of Sildenafil in HIV Associated Pulmonary Hypertension

* 06-H-0156:
A Pilot Study of the Safety and Activity of Escalating Doses of AMD3100 to Mobilize CD34+ Cells in Healthy Volunteers

* 06-H-0072:
Atorvastatin as a Disease Modifying Agent in Stage II and III Pulmonary Sarcoidosis: A Randomized, Double-Blind, Placebo-Controlled Trial

* 06-H-0054:
Evaluation of Synergy of Combining Hydroxyurea with Recombinant Human Erythropoietin Glycoform Alpha (rhu Erythropoietin-alpha) on Fetal Hemoglobin Synthesis in Patients with Sickle Cell Anemia

* 06-H-0034:
A Randomized Study of Three Immunosuppressive Regimens in Treatment Naive Patients with Severe Aplastic Anemia: Horse-ATG/CsA Taper vs Rabbit-ATG/CsA vs Alemtuzumab

* 06-EI-0252:
A Novel Non-Invasive In Vivo Imaging System to Measure Retinal Metabolism

* 06-EI-0236:
National Ophthalmic Genotyping Network Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases

* 06-EI-0230:
Family Studies of Uveal Coloboma

* 06-EI-0111:
Treatment of Choroidal Subretinal Neovascularization with Agents Directed Against the Immune Response

* 06-EI-0068:
The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease

* 06-EI-0059:
Clinical and Molecular Studies in Families with Glaucoma and Related Diseases

* 06-EI-0058:
Clinical and Molecular Studies in Families with Myopia and Related Diseases

* 06-EI-0050:
Multicenter Uveitis Steroid Treatment (MUST) Trial Protocol

* 06-EI-0046:
Treatment of Non-Infectious Intermediate and Posterior Uveitis Associated Macular Edema with Humanized Anti-CD11a Antibody Therapy

* 06-EI-0044:
Phenotype-Genotype Correlation in Aniridia

* 06-DK-0183:
Gene Expression and Release of Inflammatory Mediators in Overweight Subjects Before and After Weight Loss

* 06-DK-0142:
Peripheral Blood Collection of Adult Stem Cells

* 06-DK-0133:
Thyroid Hormone-Induced Lipolysis: An In Vivo Microdialysis Study

* 06-DK-0079:
The Role of the Orexin System in Body Weight Regulation: Patients with Narcolepsy

* 06-DK-0036:
Chronic Sleep Deprivation as a Risk Factor for Metabolic Syndrome and Obesity

* 06-DK-0025:
The Effects of Lithium Carbonate on Low Dose Radioiodine Ablation in Early Thyroid Cancer Treatment

* 06-DK-0020:
Kidney Disease Biomarkers

* 06-DC-0218:
Neural Modeling and Brain Imaging of Tinnitus

* 06-D-0206:
Open-Label, Dose-Escalation Study Evaluating the Safety of a Single Administration of AdhAQP1, an Adenoviral Vector Encoding Human Aquaporin-1 to One Parotid Salivary Gland in Individuals with Irradiation-Induced Parotid Salivary Hypofunction

* 06-D-0181:
A Randomized, Placebo Controlled, Proof of Concept, Study of Raptiva, a Humanized Anti-CD-11a Monoclonal Antibody, in Patients with Sjogren's Syndrome

* 06-CH-0223:
Biobehavioral Study of Recently Adopted Children in the Baltimore-Washington Metropolitan Area

* 06-CH-0186:
Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, Type C

* 06-CH-0141:
Non-Exercise Activity Thermogenesis (NEAT) in Children

* 06-CH-0119:
Insulin Resistance and Breast Cancer: Implications for Preventive Counseling in Familial and Sporadic Cases

* 06-CH-0038:
Body Heat Content and Dissipation in Obese and Normal Weight Adults

* 06-CH-0011:
Natural History Study of Patients with Excess Androgen

* 06-CH-0010:
Remodeling of Chromatin-Based Epigenetic Structures in Development and Aging

* 06-CC-0193:
Transplant-Related Accelerated Progression of Hepatitis C (TRAP-C)

* 06-CC-0166:
Iron Replacement in Blood Donors

* 06-CC-0153:
A Pilot Study of Hepatic Fibrosis in HIV/AIDS Patients with Chronically Elevated Transaminases on Antiretroviral Therapy

* 06-C-0250:
A Phase II Trial of Bevacizumab and Irinotecan for Patients with Recurrent High-Grade Gliomas Immediately Following Tumor Progression After Treatment w/Bevacizumab Alone: A Companion Trial to NCI Study 06-C-0064 (Bevacizumab Alone for Recurrent Gliomas)

* 06-C-0233:
A Phase I Study of the RAF Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib (BAY 43-9006, NSC# 724772 IND# 69896) in Children with Refractory Solid Tumors or Refractory Leukemias

* 06-C-0221:
A Phase I Trial of 5-Fluoro-2'-Deoxycytidine with Tetrahydrouridine in Advanced Malignancies

* 06-C-0219:
An Exploratory Study of Biologic and Pathophysiologic Effects of Radiation Therapy in Pediatric Patients with Central Nervous System Tumors

* 06-C-0211:
A Pilot Study to Investigate the Safety and Immunogenicity of a Peptide Vaccine for HIV Infected HLA-A2 Individuals Designed to Impede the Development of Antiretroviral Resistance

* 06-C-0204:
A Phase II Randomized Study of the Effect of Zoledronic Acid Versus Observation on Bone Mineral Density of the Lumbar Spine in Women Who Elect to Undergo Surgery that Results in the Removal of Both Ovaries

* 06-C-0198:
A Pilot Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity

* 06-C-0177:
Microarray Analysis of the Effect of Cyclosporine Therapy on Gene Expression Patterns in Large Granular Lymphocytic Leukemia

* 06-C-0169:
Phase II Study in Metastatic Melanoma or Kidney Cancer using Autologous Natural Killer Cells Plus Aldesleukin (IL-2) Following a Lymphodepleting Chemotherapy

* 06-C-0167:
A Phase I Trial of TNF-Bound Colloidal Gold (CYT-6091) by Intravenous Administration in Subjects with Advance Solid Organ Malignancies

* 06-C-0164:
A Phase II Study of BAY 43-9006 (Sorafenib) in Combination with Cetuximab (Erbitux) in EGFR Expressing Metastatic Colorectal Cancer (CRC)

* 06-C-0152:
Phase I Trial of CEDIRANIB (AZD2171), an Orally Bioavailable Antiangiogenic Agent, in Children and Adolescents with Refractory or Recurrent Solid Tumors or Acute Myelogenous Leukemia

* 06-C-0150:
A Phase II Clinical Trial of Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin for CD25 Positive Hairy Cell Leukemia

* 06-C-0118:
A Study Evaluating the Agreement of Devices for Measuring Temperature in Children

* 06-C-0115:
Studies on the Mechanism of Action of High-dose IL-2 in Metastatic Melanoma and Renal Cell Cancer

* 06-C-0112:
A Phase II Clinical Trial of the Histone Deacetylase Inhibitor Valproic Acid in Combination with Temodar and Radiation Therapy in Patients with High Grade Gliomas

* 06-C-0088:
A Random-Assignment Study of Hepatic Arterial Infusion of Melphalan with Venous Filtration via Peripheral Hepatic Perfusion (PHP) (Delcath System) Versus Best Alternative Care for Ocular and Cutaneous Melanoma Metastatic to the Liver

* 06-C-0083:
Phase I and Pharmacokinetic Study of BAY 43-9006 (Sorafenib) in Patients with Kaposi's Sarcoma

* 06-C-0069:
Evaluation of the Impact of Adjuvants Accompanying Peptide Immunization in High Risk Melanoma

* 06-C-0064:
A Phase II Trial of Bevacizumab for Patients with Recurrent High-Grade Gliomas

* 06-C-0063:
A Phase I/II Trial of ZD6474 for Patients with Recurrent High-Grade and Progressive Low-Grade Gliomas

* 06-C-0060:
Dermoscopic Diagnosis, Histopathological Correlation, and Cellular Immortalization of Melanocytic Nevi and Primary Cutaneous Melanoma

* 06-C-0051:
AIDS-related Primary Central Nervous System Lymphoma: A Phase II Pilot Study of High-Dose Intravenous Methotrexate with Rituximab Leucovorin Rescue and Highly Active Antiretroviral Therapy

* 06-C-0043:
Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated High Grade Unresectable Malignant Peripheral Nerve Sheath Tumors

* 06-C-0014:
Prospective Evaluation of Epigenetic Alterations in Patients with Thoracic Malignancies

* 06-AT-0016:
A Randomized Study of the Effect of Tai Chi Chuan Compared to a Structured Exercise Program on Parameters of Physical Fitness and Stress in Adult Cancer Survivors

* 05-N-0228:
The Role of Cortical Coherence in Focal Hand Dystonia

* 05-N-0224:
Cortical Excitability in Succinic Semialdehyde Dehydrogenase Deficiency

* 05-N-0223:
Clinical Neurophysiology: Training and Normative Values

* 05-N-0189:
Neuropathological Basis of Spasmodic Dysphonia and Related Voice Disorders

* 05-N-0179:
MRI Measurement of Brain Metabolism Across the Sleep-Wake Cycle

* 05-N-0142:
Effects of Unilateral and Bilateral Training on Motor Function in Chronic Stroke

* 05-N-0122:
Placebo Controlled Study of the Therapeutic Effect of the Transcranial Electrical Polarization in Patients with Focal Hand Dystonia

* 05-N-0094:
Impaired Motor Learning and LTP/LTD-like Plasticity in Dystonia, are Associated with Abnormal Modulation of Cortical Excitability by Somatosensory Volleys

* 05-N-0075:
Evaluation of the Mechanism of NO Formation and Pharmacokinetics of Long-Term Intravenous Nitrite Infusion in Healthy Volunteers

* 05-N-0063:
NINDS Biomarkers in Multiple Sclerosis Study (BioMS)

* 05-N-0039:
An Exploratory Study on Detection of Cortical Damage in Patients with Multiple Sclerosis Using Magnetic Resonance Imaging

* 05-M-0225:
An Investigation of the Efficacy in Childhood Obsessive-Compulsive Disorder of Riluzole: An Antiglutamatergic Agent

* 05-M-0198:
Effect of D-cycloserine on Treatment of Social Phobia

* 05-M-0169:
Dopamine Receptor Imaging in Mood Disorders

* 05-M-0157:
Top-Down Attentional Control of Visual Processing

* 05-M-0147:
Investigating the Role of Norepinephrine in Emotional Processing through Alpha-2 Adrenergic Receptor Modulation

* 05-M-0144:
MRS (Magnetic Resonance Spectroscopy) Measurement of Glutamate and GABA Metabolism in Brain

* 05-M-0110:
Intermediate Phenotype and Genetic Mechanisms for Psychosis and Cognitive Disturbance in 22q11.2-Hemideletion Syndrome

* 05-M-0105:
Investigating the Neuro-Cognitive Underpinnings of the Emotional Dysfunction Linked to Childhood Behavioral Disturbance

* 05-M-0102:
Neurobiological Mechanisms in Panic Disorder: Behavioral, Genetic, & Neural Correlates of Noradrenergic Function

* 05-M-0059:
5HT1A and SERT Imaging During Pharmacologically Induced Hypogonadotropic Hypogonadism With and Without Estrogen and Progesterone Replacement

* 05-M-0035:
The Effects of Mood and Tryptophan Depletion on the Neural Correlates of Affective Shifting in Mood Disorders

* 05-M-0006:
The Effect of Gabapentin on Prefrontal GABA Concentration and Emotional Processing in Healthy Humans

* 05-I-0219:
Microarray Analysis of Erythema Migrans Lesions

* 05-I-0213:
Screening and Baseline Assessment of Patients with Abnormalities of Immune Function

* 05-I-0156:
A Study of Adjuvant Cytokine Therapy in Pulmonary Mycobacterium Avium Complex Infection

* 05-I-0123:
A Randomized, Open-Label, International Study of Subcutaneous Recombinant Interleukin-2 (rIL-2, Aldesleukin) with and without Concomitant Antiretroviral Therapy in Participants w/HIV-1 Infection and CD4+ Cell Counts Greater Than or Equal to 300/mm(3)

* 05-I-0084:
Clinical and Immunological Evaluation of Children with Allergic Disease

* 05-HG-0152:
Variation in Gene Expression in Neurofibromatosis Type 1

* 05-HG-0131:
Clinical Study of Muenke Syndrome (FGFR3-Related Craniosynostosis)

* 05-H-0244:
A Pilot Study of Recombinant Humanized Anti-CD20 Antibody (Rituximab) in Patients with Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia

* 05-H-0242:
A Pilot Study of Alemtuzumab (Campath) in Patients with Relapsed or Refractory Severe Aplastic Anemia

* 05-H-0206:
A Pilot Study of Alemtuzumab (Campath[R]) in Patients with Myelodysplastic Syndrome (MDS)

* 05-H-0130:
Long-Term Evaluation and Follow Up Care of Patients Treated with Allogeneic Stem Cell Transplants

* 05-H-0019:
A Prospective, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Nitric Oxide for Inhalation in the Acute Treatment of Sickle Cell Pain Crisis

* 05-EI-0143:
Molecular Genetics of Retinal Degenerations

* 05-EI-0104:
Familial Exudative Vitreoretinopathy Clinical and Molecular Studies

* 05-EI-0096:
Natural History and Genetic Studies of Usher Syndrome

* 05-DK-0119:
Peripheral Thyroid Hormone Conversion and Glucose and Energy Metabolism

* 05-DK-0085:
Clinical and Laboratory Investigation of Humans with Informative Iron or Erythroid Phenotypes

* 05-DK-0015:
Retinoids for Podocyte Disease

* 05-D-0103:
Genes Associated with Hereditary and Drug-Induced Gingival Overgrowth

* 05-D-0058:
Salivary Proteomics in Disease and Health

* 05-D-0052:
Stereo Photogrammetry Soft Tissue in Normal Individuals and Patients with Craniofacial Dysmorphologies

* 05-D-0050:
Selective Venous Catheterization for the Localization of Phosphaturic Mesenchymal Tumors

* 05-CH-0204:
Hypertonia in Patients with Cerebral Palsy

* 05-CH-0168:
Short-Term Behavioral Effects of Cholesterol Therapy in Smith-Lemli-Opitz Syndrome

* 05-CH-0013:
Adrenal Function in Critical Illness

* 05-CC-0216:
Prospective Assessment of Functional Status, Psychosocial Adjustment, Health Related Quality of Life and the Symptom Experience in Patients Treated with Allogeneic Hematopoietic Stem Cell Transplantation

* 05-CC-0127:
Assessing the Relationship Between Fatigue and Mitochondrial Toxicity in Patients with HIV/AIDS

* 05-CC-0091:
Electromagnetic Tracking of Devices During Interventional Procedures: A Pilot Study

* 05-CC-0082:
The Influence of Concurrent Administration of Echinacea Purpurea, Ginkgo Biloba, or Panax Ginseng on the Steady State Pharmacokinetic Profile of Lopinavir/ritonavir in Healthy Volunteers

* 05-CC-0062:
Evaluation of Patients with Critical Illness: Intensive Care Training Protocol

* 05-CC-0041:
Endothelial Cell Dysfunction in Pulmonary Arterial Hypertension: Biomarkers, Mechanisms of Disease and Novel Therapeutic Targets

* 05-CC-0012:
Effects of Inhaled Carbon Monoxide on Pulmonary Inflammatory Responses Following Endotoxin Instillation

* 05-C-0252:
Phase III Randomized Study of R-CHOP v. Dose-Adjusted EPOCH-R with Molecular Profiling in Untreated de Novo Diffuse Large B-Cell Lymphomas

* 05-C-0241:
A Pilot Study of Image Guided Prostate and Pelvic Nodal Irradiation with Intensity Modulated Radiation Therapy (IMRT) in Prostate Cancer

* 05-C-0229:
A Randomized Pilot Phase II Study of Docetaxel alone or in Combination with PANVAC-V (Vaccinia) and PANVAC-F (Fowlpox) in Adults with Metastatic Breast Cancer

* 05-C-0191:
A Phase I Study of Image Guided Dose Escalation with Intensity Modulated Radiation Therapy (IMRT) to Histologically Confirmed Regions of Prostate Cancer

* 05-C-0186:
A Pilot Trial of Oral Topotecan for the Treatment of Refractory Advanced Solid Neoplasms Expressing HIF-1 Alpha

* 05-C-0185:
Phase II Study of the Efficacy and Toxicity of Ontak (Denileukin Diftitox) in the Therapy of Adult T-Cell Leukemia

* 05-C-0170:
Randomized Phase II Study of Dose-Adjusted EPOCH-Rituximab-Bortezomib (EPOCH-R-B) Induction Followed by Bortezomib Maintenance versus Observation in Untreated Mantle Cell Lymphoma with Microarray Profiling and Proteomics

* 05-C-0150:
A Study of Central Nervous System Disease in Pediatric HIV in the HAART Era

* 05-C-0137:
A Phase II Trial of Tamoxifen and Bortezomib in Patients with Recurrent High-Grade Gliomas

* 05-C-0095:
A Randomized Phase II Study of Oral Lenalidomide (Revlimid [TM]), an Antiangiogenic and Immunomodulatory Agent, in Subjects with Stage IV Ocular Melanoma

* 05-C-0049:
Phase II Study of Bay 43-9006 (Sorafenib) with Evaluation of RAS Signal Pathway in Patients with Relapsed Non-Small Cell Lung Cancer

* 05-C-0044:
Immunologic Studies of Tumors of the Pancreas

* 05-C-0017:
A Phase I Feasibility Study of an Intraprostatic PSA-Based Vaccine in Men with Prostate Cancer and Local Failure Following Radiotherapy or Cryotherapy or Clinical Progression on Androgen Deprivation Therapy in the Absence of Local Definitive Therapy

* 05-C-0010:
Phase I Study of Sequential Depsipeptide/Flavopiridol Infusion for Malignancies Involving Lungs, Esophagus, Pleura, Thymus or Mediastinum

* 05-AR-0014:
Continuation of a Pilot Open-Label Study of IL 1 Trap in Adult Subjects with Autoinflammatory Disease: A Therapeutic Approach to Study Pathogenesis

* 05-AA-0121:
Assessment and Treatment of People with Alcohol Drinking Problems

* 05-AA-0120:
Acamprosate for Central Nervous System Hyperexcitability and Neuroadaptation in Alcohol Withdrawal

* 04-NR-0069:
Evaluation of Efficacy and Mechanisms of Topical Thalidomide for Chronic Graft-Versus-Host-Disease Related Stomatitis

* 04-N-0264:
MR Rescue: MR and Recanalization of Stroke Clots using Embolectomy

* 04-N-0212:
Enhancement of Rehabilitative Treatment-Dependent Functional Recovery After Stroke by Transcranial Direct Current Stimulation (tDCS)

* 04-N-0210:
Towards the Establishment of Standards of Practice and the Initiation of Multi-Center, Multi-National Clinical Trials for Neonates and Children With Stroke

* 04-N-0159:
Functional MRI (fMRI) and Diffusion Tensor Imaging (DTI) in Temporal Lobe Epilepsy

* 04-N-0113:
Examining Associative Relations in Structured Event Complexes Using Functional Neuroimaging

* 04-N-0103:
Changes in Intracortical Inhibitory Processes are Associated With the Development of Implicit Learning of a Motor Task

* 04-N-0071:
Phase I/II Study of HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Using the Humanized MiK-beta-1 Monoclonal Antibody Directed Toward the IL-2/IL-15Rbeta Subunit (CD122) that Blocks IL-15 Action

* 04-N-0033:
MRI in Autosomal Dominant Partial Epilepsy with Auditory Features

* 04-M-0270:
Investigating the Role of Serotonin in Emotional Processing Through the Use of Tryptophan Depletion

* 04-M-0227:
Combining a Dopamine Agonist and Selective Serotonin Reuptake Inhibitor for Treatment of Depression: A Double-Blind, Randomized Study

* 04-M-0222:
Investigation of the Rapid (Next Day) Antidepressant Effects of an NMDA Antagonist

* 04-M-0221:
The Treatment of Menstrually-Related Mood Disorders with Extended Versus Interrupted Oral Contraceptives

* 04-M-0183:
Association Between Adenosine Receptor Gene Polymorphisms and Physiological Responses to Caffeine in Subjects with Panic Disorder and Healthy Controls

* 04-M-0160:
Neural Correlates of Depressive Symptoms and Reward Related Mechanisms Following AMPT Depletion in Remitted Depressed Patients Off Treatment and Healthy Controls

* 04-M-0139:
The Effects of Dutasteride on Mood, HPA Axis, and Serum Allopregnanolone Levels in Women with Menstrual-Related Mood Disorders and Controls

* 04-M-0091:
An Investigation of a Pharmacologic Strategy to Bring About Rapid (Next Day) Antidepressant Effects

* 04-M-0002:
The Functional Neuroanatomy of Emotion Regulation in Major Depressive Disorder (MDD)

* 04-I-0286:
A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression

* 04-I-0231:
Procurement of Clinical Specimens for Immunologic or Genetic Studies in Inflammatory Bowel Diseases

* 04-I-0086:
Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research on HCV-Infected Patients

* 04-I-0030:
Clinical Evaluation and Management of Persons with Severe Acute Respiratory Syndrome (SARS)

* 04-HG-0226:
Investigations of Megakaryocytes from Patients with Abnormal Platelet Vesicles

* 04-HG-0211:
Specimen Procurement From Individuals With Pulmonary Fibrosis

* 04-HG-0127:
Clinical and Basic Investigations of Methylmalonic Acidemia (MMA) and Related Disorders

* 04-HG-0123:
Bardet-Biedl Syndrome: Phenotype and Metabolic Characteristics

* 04-HG-0093:
Clinical and Genetic Studies on Holoprosencephaly

* 04-H-0202:
Human Diseases with Mutation of Non-Muscle Myosin Heavy Chain Genes

* 04-H-0179:
Peripheral Blood Hematopoietic Progenitor Cell Mobilization Using Granulocyte Colony Stimulating Factor (G-CSF) Combined With AMD3100 in Healthy Volunteers

* 04-H-0161:
Studies of the Natural History of Sickle Cell Disease and Other Hemolytic Disorders

* 04-H-0143:
Modulation of Vascular Endothelial Growth Factor (VEGF) Using an Engineered Zinc-Finger Transcription Factor to Treat Lower Limb Intermittent Claudication

* 04-H-0090:
A Pilot Study of the Safety and Efficacy of Imatinib in Reducing Monocytosis or Leukocytosis in Patients with Chronic Myelomonocytic Leukemia and Atypical Chronic Myelogenous Leukemia, Respectively

* 04-H-0078:
Peripheral Blood Hematopoietic Progenitor Cell Mobilization with AMD3100 in Healthy Volunteers Previously Mobilized with G-CSF

* 04-H-0012:
Collection of Blood, Bone Marrow, Urine, and/or Tissue Samples from Patients with Solid Tumors, Hematological Malignancies or Non-Malignant Hematologic Disorders or HLA Compatible Family Members

* 04-EI-0260:
Use of Immune Cell Markers, Cytokines, Transcription Factors and Surface CD Markers as Markers of Ocular Inflammatory Activity

* 04-EI-0039:
Evaluation and Treatment of Pediatric, Developmental and Genetic Eye Diseases

* 04-EI-0008:
Clinical and Molecular Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases

* 04-DK-0061:
A Comparison of Free Fatty Acid Flux in African Americans and Caucasians

* 04-DK-0021:
Urinary Vitamin C Loss in Subjects with and without Diabetes

* 04-D-0267:
Clinical Research Core Dental Screening Protocol

* 04-CH-0250:
Event Related Potentials in Infants and Adults

* 04-CH-0077:
Screening and Diagnosis of Patients With Connective Tissue Disorders

* 04-CH-0056:
The Neural Immune Mechanisms and Genetic Influences on Chronic Pelvic Pain in Women with Endometriosis

* 04-CH-0050:
Eating Behavior in Children

* 04-CC-0178:
The Treatment of Deep Vein Thrombosis of the Lower Extremities with "Low-Dose" Alteplase: a Pilot Study

* 04-CC-0119:
Biomarkers and Protein Mass Expression Profiles in Bronchoalveolar Lavage from Patients with Lung Infiltrates

* 04-C-0281:
Natural History Study of Clinical and Biological Factors Determining Outcomes in Chronic Graft-Versus-Host Disease

* 04-C-0275:
Targeted Oncolytic Virotherapy and Natural History Study of KSHV-Associated Multicentric Castleman's Disease with Laboratory and Clinical Correlates of Disease Activity

* 04-C-0274:
Follow-Up of Study Subjects Previously Enrolled in Immunotherapy Studies Utilizing Gene Transfer

* 04-C-0273:
A Phase II Study of Hepatic Arterial Infusion of Melphalan with Venous Filtration via Peripheral Hepatic Perfusion (PHP) for Unresectable Primary and Metastatic Cancers of the Liver

* 04-C-0257:
A Phase II Trial of Docetaxel, Thalidomide, Prednisone and Bevacizumab in Patients with Androgen-Independent Prostate Cancer

* 04-C-0238:
A Phase II Study of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Von Hippel Lindau Disease and Renal Tumors

* 04-C-0232:
A Multi-Institutional Study of Proteomic Evaluation of Epithelial Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer Patients in First Clinical Remission: Development of a Protein Fingerprint Profile of Relapse

* 04-C-0200:
Urinary and Serum VEGF and MMP Levels in Patients Receiving Radiation Therapy for Glioblastoma Multiforme: Prospective Determination of a Predictive Value for Recurrence

* 04-C-0199:
Procurement of Normal Breast Tissue and Metastatic Breast Cancer Tissue for Molecular Profiling

* 04-C-0177:
A Pilot Study of Tc-94m Sestamibi PET MDR Imaging

* 04-C-0173:
Phase II Study of UCN-01 in Relapsed or Refractory Systemic Anaplastic Large Cell and Mature T-Cell Lymphomas

* 04-C-0165:
Medical Oncology Care in the NCI, Center for Cancer Research

* 04-C-0155:
Barrett's Esophagus Early Detection Study

* 04-C-0142:
A Phase II Clinical Trial of Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin for Treatment of CD25 Positive Cutaneous T-Cell Lymphomas

* 04-C-0138:
Detection and Quantification of Changes in Levels of Protein Expression and Phosphorylation Status Using Human Hair Samples

* 04-C-0131:
Allogeneic Breast Protocol 2: Phase I Trial of T cell Exchange with Th2/Tc2 Cells for Allogeneic Stem Cell Transplantation after Reduced Intensity Conditioning for Metastatic Breast Cancer

* 04-C-0121:
A Phase II Clinical Trial of Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin for Treatment of CD25 Positive Chronic Lymphocytic Leukemia

* 04-C-0116:
T-Cell Depleted, Reduced-Intensity Allogeneic Stem Cell Transplantation from Haploidentical Related Donors for Hematologic Malignancies (HAPLO Part A)

* 04-C-0102:
Hematologic Malignancy Biology Study

* 04-C-0089:
Phase I Open-Label Single-Dose Study of Humanized Mik-Beta-1 Monoclonal Antibody Directed Toward The IL-2R/IL-15R-Beta Subunit (CD122) in T Cell Large Granular Lymphocytic Leukemia

* 04-C-0081:
Pathogenesis and Course of Cutaneous T-Cell Lymphoma

* 04-C-0079:
Pediatric Phase I Trial of BL22 for Refractory CD22-Positive Leukemias and Lymphomas

* 04-C-0055:
Allogeneic HSCT without Preparative Chemotherapy or with Low-Intensity Preparative Chemotherapy using Sirolimus and Sirolimus-Generated Donor Th2 Cells for Therapy of Refractory Leukemia, Lymphoma, Myeloma, or Myelodysplastic Syndrome

* 04-C-0049:
A Phase I/II Study of an Antitumor Vaccination Using Alpha (1,3) Galactosyltransferase Expressing Allogeneic Tumor Cells in Patients with Refractory or Recurrent Non-Small Cell Lung Cancer

* 04-C-0014:
Phase II Trial of BL22 Immunotoxin in Hairy Cell Leukemia

* 04-C-0011:
A Study of Combination Chemotherapy & Surgical Resection in the Tx of Adrenocortical Cancer: Mitotane & Continuous Infusion Doxorubicin, Vincristine & Etoposide w/the P-glycoprotein Antagonist, Tariquidar (XR9576), Before & After Surgical Resection

* 04-C-0001:
Phase II Study of Sequential Gemcitabine Followed by Docetaxel for Recurrent Ewing's Sarcoma, Osteosarcoma, or Unresectable or Locally Recurrent Chondrosarcoma

* 04-AR-0205:
Progression of Spinal Fusion in Ankylosing Spondylitis

* 04-AA-0060:
The Effect of Ethanol on Cerebral Blood Flow as Measured by Functional Magnetic Resonance Imaging and the Development of Conditioned Response to Ethanol Administration

* 04-AA-0058:
Positron Emission Tomography Imaging of Incorporation of Docosahexaenoic Acid (DHA) from Plasma into Human Brain

* 03-N-0260:
Functional Brain Mapping of Laryngeal Sensorimotor Control in Voice Disorders

* 03-N-0224:
Remote Effects of Stroke on Cerebral Metabolism. Evaluation with Positron Emission Tomography and Proton Magnetic Resonance Spectroscopy

* 03-N-0220:
Safety Study of the Super Rapid Transcranial Magnetic Stimulation in Patients with Parkinson's Disease

* 03-N-0196:
Social Knowledge Representation in the Human Prefrontal Cortex

* 03-N-0171:
Combination Anti-platelet and Anti-coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST)

* 03-N-0164:
Evaluation and Treatment of Neurosurgical Disorders

* 03-N-0142:
Development of 7 Tesla MRI Methodology for Anatomical Functional and Spectroscopic Imaging of the Brain

* 03-N-0134:
Neurophysiological Studies in Patients With Psychogenic Movement Disorders

* 03-N-0126:
Spatiotemporal Dynamics of Cortical Connectivity Involved in Tics and Voluntary Movements in Patients With Tourette's Syndrome and Chronic Motor Tic Disorder: An EEG Study

* 03-N-0119:
The Effects of an NMDA-Receptor Antagonist in Idiopathic Voice Disorders

* 03-N-0116:
Transcranial Electrical Polarization for the Treatment of Bradykinesia and Rigidity in Patients with Parkinson's Disease

* 03-N-0004:
Clinical Laboratory Evaluation of Primary Chronic Autonomic Failure

* 03-M-0292:
Psychobiological Mechanisms of Resilience to Trauma

* 03-M-0211:
Family Study of Affective and Anxiety Spectrum Disorders

* 03-M-0186:
The Psychobiology of Temperament: An fMRI Study

* 03-M-0185:
Generalized Anxiety Disorder and Social Anxiety Disorder: Their Impact on the Processing of Social Emotional Information and Instrumental Learning

* 03-M-0175:
The Effects of Acute Withdrawal of Estradiol on Mood Symptoms in Women with Perimenopausal Depression

* 03-M-0161:
The Efficacy of 17Beta-Estradiol in Postpartum-Related Depressive Illness

* 03-M-0149:
Functional MRI Study of Brain Mechanism Mediating Anhedonia in Major Depression

* 03-M-0143:
Randomized, Double-Blinded, Placebo Controlled Study of the Effects of Modafinil on Cognitive Function in Patients with Schizophrenia and Normal Controls Based on COMT Genotype

* 03-M-0138:
A Screening Protocol to Evaluate Women with Postpartum-Related Mood and Behavioral Disorders

* 03-M-0108:
Cholinergic Modulation of Cognition and Emotion in Mood Disorders: Functional Neuroimaging Studies

* 03-M-0102:
Effects of Hydrocortisone Infusion on Processing of Facially Expressed Emotion During Functional Magnetic Resonance Imaging

* 03-M-0093:
Predictability and Aversive Expectancies in Anxiety Disorders

* 03-M-0092:
An Investigation of the Antidepressant Efficacy of an Antiglutamatergic Agent in Bipolar Depression

* 03-M-0035:
Screening, Evaluation, Diagnosis, Treatment Optimization and Follow-up for Childhood Onset Psychotic Disorders

* 03-M-0014:
Neural Circuitry and Risk for Depression in Adolescents: A Study Using Functional Magnetic Resonance Imaging

* 03-M-0001:
Muscarinic Cholinergic Receptor Imaging in Depression

* 03-I-0285:
VRC 300: Screening of Healthy Volunteers for Clinical Trials of Investigational Vaccines to Prevent Infectious Diseases

* 03-I-0263:
Apheresis and Specimen Collection Procedures to Obtain Plasma, Peripheral Blood Mononuclear Cells (PBMCs) and Other Specimens for Research Studies

* 03-I-0151:
Evaluation and Treatment of Persons with Serious Complications Associated with Vaccinia Vaccination

* 03-I-0090:
Immune Responses to Vaccinia Virus Vaccination

* 03-I-0079:
Screening HIV-Infected Subjects for Vaccine Research Studies

* 03-I-0041:
Determining the Pathogenesis of Systemic Pediatric-Onset Mastocytosis

* 03-I-0025:
Treatment of Chronic Graft Versus Host Disease with Extracorporeal Photopheresis

* 03-HG-0313:
Genetic Analysis of Gray Platelet Syndrome

* 03-HG-0264:
Clinical Investigations into the Kidney and Liver Disease in Autosomal Recessive Polycystic Kidney Disease/Congenital Hepatic Fibrosis and other Ciliopathies

* 03-H-0280:
Disease Pathogenesis and Natural History of Lipid Disorders

* 03-H-0250:
Technical Development of Interventional Cardiovascular Magnetic Resonance Imaging

* 03-H-0249:
A Randomized Trial of Immunosupression in Aplastic Anemia Patients with Refractory Pancytopenia or Suboptimal Hematologic Response After h-ATG/CsA Treatment

* 03-H-0170:
Nonmyeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation For Severe Congenital Anemias Including Sickle Cell Anemia, Thalassemia, and Diamond Blackfan Anemia

* 03-H-0168:
Peripheral Blood Granulocyte Mobilization and Gene Expression Profiling in Adult Individuals of African Descent, With and Without Benign Ethnic Neutropenia

* 03-H-0105:
The Determination Of Genetic Basis Of Immunodeficiency

* 03-H-0051:
Collection of Blood, Stool, Bone Marrow and/or Tissue Samples from Subjects with Hepatitis-Associated Aplastic Anemia

* 03-EI-0255:
Pilot Study on the Effect of Vitamin A Supplementation on Cone Function in Retinitis Pigmentosa

* 03-EI-0155:
Evaluation of Single Nucleotide Polymorphism (SNP) in Patients with and Subjects without Age-Related Macular Degeneration (AMD)

* 03-EI-0123:
Clinical and Molecular Studies in Families with Congenital or Hereditary Cataracts

* 03-EI-0122:
Evaluation of Immune Responses to Different Antigens in Non Infectious Ocular Inflammatory Diseases

* 03-EI-0033:
X-Linked Juvenile Retinoschisis - Clinical and Molecular Studies

* 03-E-0099:
Pathogenic Studies In Families With Twins Or Siblings Discordant For Systemic Rheumatic Disorders

* 03-DK-0257:
Effect of Leptin Therapy in the Treatment of Severe Insulin Resistance

* 03-DK-0256:
Inhibition of Intestinal Glucose Absorption by the Bioflavonoid Quercetin in the Obese and in Obese Type 2 Diabetics

* 03-DK-0226:
Pulse Dexamethasone Over 48 Weeks for Podocyte Disease

* 03-DK-0098:
Study of Thyrotropin Releasing Hormone in Patients with Thyroid or Pituitary Abnormalities

* 03-CH-0225:
Investigation of Simvastatin Therapy in Smith-Lemli-Opitz Syndrome

* 03-CH-0069:
Early Learning and Development Project

* 03-CH-0060:
Virtual Functional Anatomy (VFA)

* 03-CC-0128:
Development and Evaluation of Techniques for Computer Aided Detection and Diagnosis from Radiologic Images

* 03-CC-0015:
Collection of Blood from Volunteers and Patients for Studies of Endothelial Function and Systemic Inflammation

* 03-C-0304:
Pilot Trial of Alemtuzumab and Dose-Adjusted Epoch in Chemotherapy Naive Aggressive T and NK-Cell Lymphomas

* 03-C-0300:
A Phase II Randomized Trial Comparing TNFerade[TM] Biologic with Capecitabine and Radiation Therapy Followed by Surgical Resection Versus Capecitabine and Radiation Therapy Followed by Surgical Resection for the Treatment of Rectal Cancer

* 03-C-0284:
A Clinical Trial of the P-Glycoprotein Antagonist, Tariquidar (XR9576), in Combination With Docetaxel in Patients With Lung, Ovarian, Renal and Cervical Cancer: Analysis of the Interaction Between Tariquidar and Docetaxel

* 03-C-0278:
A Comparative Study of Pediatric CNS Tumor Activity as Assessed by [18]F-FDG PET Imaging and Proton Magnetic Resonance Spectroscopic Imaging ([1]H-MRSI)

* 03-C-0277:
Cell Harvest and Preparation for Surgery Branch Adoptive Cell Therapy Protocols

* 03-C-0241:
The Natural History of Childhood Malignancies Treated with Radiation Therapy

* 03-C-0216:
A Groupwide Biology and Banking Study for Ewing Sarcoma: Children's Oncology Group

* 03-C-0194:
Phase II Study of the Efficacy and Toxicity of Campath-1H in the Therapy of Adult T-Cell Leukemia

* 03-C-0148:
Genetic Mutation Analysis in a VHL Population

* 03-C-0145:
Evaluation of the Natural History and Management of Pancreatic Lesions Associated with Von Hippel-Lindau

* 03-C-0110:
Phase II Study of Intravenous Recombinant Humanized Anti-Vascular Endothelial Cell Growth Factor Antibody (Bevacizumab) in Classical (HIV-Negative) and in AIDS-Associated Kaposi's Sarcoma

* 03-C-0066:
Hereditary Leiomyomatosis Renal Cell Cancer (HLRCC): Identification of the Disease Gene and Characterization of the Predisposition to Renal Cancer

* 03-C-0040:
A Phase I-II Study of Tumor Vaccine Following Chemotherapy in Patients with Metastatic Breast Cancer Untreated with Chemo/Radiation in the Previous 18 Months: Vaccine-Induced Bias of T-Cell Repertoire Reconstitution After T-Cell Re-Infusion

* 03-C-0030:
Phase I Trial of Romidepsin Given on Days One, Three, and Five in Patients with Thyroid and Other Advanced Cancers

* 03-AR-0298:
A Pilot Study with the IL-1 Receptor Antagonist Anakinra or Kineret in Patients with Neonatal Onset Multisystem Inflammatory Disease (NOMID/CINCA Syndrome)

* 03-AR-0173:
Studies of the Natural History and Pathogenesis of Neonatal Onset Multisystem Inflammatory Disease (NOMID)

* 03-AR-0133:
Clinically Important Changes in Rheumatoid Arthritis

* 03-AR-0131:
Genetic Determinants of Ankylosing Spondylitis Severity - Longitudinal Study

* 03-AA-0283:
Influence of Age and Sex on Alcohol Metabolism and Acute Responses

* 03-AA-0013:
Brain Activation in Response to Motivational and Affective Stimuli: Pharmacological Manipulations

* 02-NR-0133:
Evaluation of Efficacy and Mechanisms of an Antiinflammatory Intervention for Chemotherapy Related Mucosal Injury

* 02-N-0223:
fMRI Languages Studies In Young Children

* 02-N-0216:
Dopaminergic Modulation of Cerebral Connectivity during Sequential Finger Movements

* 02-N-0181:
Evaluation of Density and Pattern of Distribution of GABA A Receptors in Brain of Patients with Tourette's Syndrome Studied with PET using [11C] Flumazenil

* 02-N-0132:
In Vivo Mapping Of Structural and Biochemical Abnormalities In Patients With Primary Focal Dystonia

* 02-N-0128:
Evaluation of Tourette's Syndrome with Multimetabolite H-Magnetic Resonance Spectroscopy at 3T

* 02-N-0109:
Real-time Analysis of Scalp Electroencephalography and Magnetoencephalography During Production of Human Voluntary Movement

* 02-N-0104:
Interhemispheric Interactions Associated with Performance of Voluntary Movements in Patients with Stroke Motor Disability

* 02-N-0014:
Research Study of Specimens Obtained During Epilepsy Surgery

* 02-N-0010:
EEG Study of Movement-Related Center-Surround Organization in Hand Dystonia

* 02-N-0001:
Testing A Model of the Representational Knowledge Stored in the Human Prefrontal Cortex

* 02-M-0321:
fMRI Investigation of Explicit Cue and Contextual Fear

* 02-M-0263:
Psychopharmacology of Fear-Potentiated Startle in Humans

* 02-M-0239:
Randomized, Double-Blinded, Placebo Controlled Study of the Effects of Tolcapone and Entacapone on Cognitive Function in Patients With Schizophrenia and Normal Controls Based on COMT Genotype

* 02-M-0120:
The Efficacy of Phytoestrogens and Selective Estrogen Receptor Modulators in Perimenopause-Related Depression

* 02-M-0047:
Serotonin1A Receptor and Serotonin Transporter Imaging In Mood Disorders

* 02-M-0021:
Severe Mood and Behavioral Dysregulation in Children: Pathophysiology and Treatment with Lithium

* 02-M-0007:
Adolescent Medial Temporal Lobe Function in Health and Illness

* 02-M-0003:
Fear Conditioning Using Computer-Generated Virtual Reality

* 02-I-0308:
Study of Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) for the Evaluation of the Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-Associated Lymphoma

* 02-I-0286:
A Pilot Study of the Safety and Efficacy of Imatinib Mesylate in Reducing Eosinophilia in Patients with the Myeloproliferative Variant Hypereosinophilic Syndrome (HES) or Non-Myeloproliferative HES Refractory to Standard Therapy

* 02-I-0277:
Regulation of the Proliferation and Survival of Normal and Neoplastic Human Mast Cells

* 02-I-0232:
HIV Expression in Patients with Viral Loads Suppressed on HAART

* 02-I-0202:
Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-Infected Patients

* 02-I-0147:
Genetic Studies of Chronic Active Epstein-Barr Virus Infection

* 02-I-0127:
Screening Subjects for HIV Vaccine Research Studies

* 02-I-0110:
Natural History of Anthrax: A Study of Primary Infected, Recovered, and Exposed (SPoRE) Individuals and Evaluation of AVA Vaccinated Recipients

* 02-I-0096:
Rituximab (Anti-CD20) for the Treatment of Hepatitis C Associated Cryoglobulinemic Vasculitis

* 02-I-0086:
Leukapheresis Procedures to Study HIV-Specific Immunity

* 02-I-0057:
Ex Vivo Retroviral Gene Transfer For Treatment of X-Linked Severe Combined Immunodeficiency (XSCID)

* 02-I-0055:
Evaluation, Treatment and Follow up of Patients with Lyme Disease

* 02-H-0250:
A Phase I/II Study of HLA-matched Mobilized Peripheral Blood Hematopoietic Stem Cell Transplantation for Advanced Mycosis Fungoides/Sezary Syndrome Using Nonmyeloablative Conditioning with Campath-1H

* 02-H-0160:
Peripheral Blood Stem Cell Collection from Adult Volunteers

* 02-DK-0107:
Investigation of Neurodegeneration in Glycosphingolipid Storage Disorders

* 02-DK-0022:
Long-Term Efficacy of Leptin Replacement in Treatment of Lipodystrophy

* 02-CH-0311:
Investigations into Inborn Errors of Cholesterol Synthesis and Related Disorders

* 02-CH-0195:
Human MATER and Idiopathic Infertility

* 02-CH-0023:
Studies of Pediatric Patients with Metabolic or Other Genetic Disorders

* 02-CC-0266:
Acute Cardiac Allograft Cellular Rejection and Cardiac Allograft Vasculopathy: Identification of Diagnostic Biomarkers and Target Pathways for Preventive Therapy

* 02-CC-0247:
Values at the Bedside: A Survey of European Physicians Regarding Ethical Dilemmas in Clinical Practice

* 02-CC-0245:
The Natural History of Upper Trapezius Myofascial Trigger Points: Comparison of Local and Remote Tissue Milieu in Normal Muscle, Latent and Active Myofascial Trigger Points Over Time

* 02-CC-0045:
A Prospective (Cohort) Study to Identify Factors Affecting Morbidity Following the Diagnosis and Treatment of Patients with Breast Cancer: A Multi-Institutional Study Between NIH/RMD and NNMC/BCC

* 02-C-0313:
Cancer Risk in Xeroderma Pigmentosum Heterozygotes

* 02-C-0284:
A Pilot study of MDX-CTLA-4 in Lymphoma

* 02-C-0259:
Pilot Study of Allogeneic/Syngeneic Blood Stem Cell Transplantation in Patients with High-Risk and Recurrent Pediatric Sarcomas

* 02-C-0258:
Acquisition of Blood, Bone Marrow, Tumor, or Tissue Samples

* 02-C-0212:
Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer

* 02-C-0211:
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma

* 02-C-0210:
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Blood and Lymph Node Malignancy

* 02-C-0205:
Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects with Pulmonary and Pleural Malignancies

* 02-C-0193:
A Phase II Study Of Pegylated Interferon Alfa-2b (Peg-Intron (TM)) In Children With Diffuse Pontine Gliomas

* 02-C-0192:
Detection and Quantification of Circulating Endothelial Cells (CECs) and Circulating Endothelial Cell Precursors (CEPs) in Peripheral Blood

* 02-C-0186:
Eligibility Screening of Patients with CNS Tumors for NCI Clinical Research Protocols

* 02-C-0179:
Collection of Blood from Patients with Cancer

* 02-C-0178:
Multidisciplinary Etiologic Study of Familial Testicular Cancer

* 02-C-0159:
The Birt Hogg-Dube Syndrome: Identification of the Disease Gene and Characterization of the Predisposition of Renal Cancer

* 02-C-0149:
A Phase I Trial of High Dose Ketoconazole Plus Weekly Docetaxel in Metastatic Androgen Independent Prostate Cancer

* 02-C-0144:
Establishment of Normal High Risk Breast Epithelial Cell Cultures, and A High Risk Cell Line and Tissue Repository from Breast Tissue from Women at High Risk of Breast Cancer

* 02-C-0140:
A Prospective National Study to Molecularly and Genetically Characterize Human Gliomas: The Glioma Molecular Diagnostic Initiative

* 02-C-0130:
A Phase II Clinical Trial of BMS-247550 (NSC710428), an Epothilone B Analog, in Renal Cell Carcinoma

* 02-C-0077:
Characterization of High Risk Breast Duct Epithelium by Cytology, Breast Duct Endoscopy, and cDNA Gene Expression Profile

* 02-C-0064:
Collection of Peripheral Blood and/ or Urine From Patients Undergoing Radiation Therapy

* 02-C-0052:
Etiologic Investigation of Cancer Susceptibility in Inherited Bone Marrow Failure Syndromes: A Natural History Study

* 02-C-0031:
Phase I Trial and Pharmacokinetic Study of BMS-247550 (NSC 710428, Ixabepilone), an Epothilone B Analog, in Pediatric Patients with Refractory Solid Tumors and Leukemias

* 02-AT-0172:
A Randomized Study of Electroacupuncture Treatment for Delayed Chemotherapy-Induced Nausea and Vomiting in Patients with Pediatric Solid Tumors

* 02-AR-0131:
Collection Of Blood Components Using Apheresis From Patients With Rheumatic Diseases And Healthy Volunteers

* 01-N-0206:
Phenotype/Genotype Correlations in Movement Disorders

* 01-N-0148:
Spasticity: Physiologic Studies

* 01-N-0147:
Trial of Amlodipine Combined with Botulinum Toxin Injections for Focal Dystonia

* 01-N-0145:
Screening: Neurologic Disorders with Muscle Stiffness

* 01-N-0139:
Evaluation and Treatment of Patients with Epilepsy

* 01-N-0085:
Establishing the Pathophysiology of Primary Spinal Syringomyelia

* 01-N-0007:
Evaluation, Pathogenesis, and Treatment of Patients with or at Risk For Cerebrovascular Disease (A Natural History/Disease Pathogenesis Protocol)

* 01-M-0254:
The Evaluation of Patients with Mood and Anxiety Disorders and Healthy Volunteers

* 01-M-0232:
Positron Emission Tomography (PET) Scanning in Dopamine Disorders: Parkinson's Disease and Schizophrenia

* 01-M-0192:
Fluoxetine's Effects on Attention and Emotional Memory in Anxious and Depressed Youth and Adults

* 01-M-0185:
Effects of Arousal and Stress on Classical Conditioning

* 01-M-0152:
Adolescence, Puberty, Hormones, and Emotion Regulation: An fMRI Study

* 01-I-0238:
Diagnosis and Treatment of Leishmanial Infections

* 01-I-0226:
Evaluation of Immune Response to Vaccines in Primary Immune Disorders

* 01-I-0225:
An Omnibus Proleukin (IL-2) Trial in HIV-Infected Patients Including Interrupted Versus Continuous Antiretrovirals (OPTICA): A Substudy of Interrupted Versus Continuous Antiretrovirals Involving Randomization From the Umbrella Study (ICARUS)

* 01-I-0202:
Natural History, Genetics, Phenotype and Treatment of Mycobacterial Infections

* 01-I-0194:
A Non-Randomized, Open label, Study to Assess Hepatitis C Viral Kinetics in Predicting the Clinical Response in Patients with Hepatitis C Infection Coinfected with HIV-1 Treated with Peginterferon Alpha-2b and Ribavirin

* 01-I-0161:
Identification of Novel Viruses

* 01-I-0153:
The Immune Basis for the Gastrointestinal Complications of Common Variable Immunodeficiency

* 01-I-0004:
An Assessment of the Relationship Between Antiretroviral Drug Genotype/Phenotype (IC50) and Antiretroviral Activity in HIV-Infected, Drug-Experienced Patients with Suboptimal Suppression of Plasma Viral Load

* 01-HG-0189:
Treatment of SCID due to ADA Deficiency with Autologous Cord Blood or Bone Marrow CD34+ Cells Transduced with a Human ADA Gene

* 01-HG-0109:
Natural History Study of the Clinical and Molecular Manifestations of Smith-Magenis Syndrome (SMS)

* 01-HG-0106:
National Human Genome Research Institute Training Protocol

* 01-HG-0094:
Molecular Analysis of Microphthalmia/Anophthalmia and Related Disorders

* 01-H-0198:
Clinical Course in Cystic Fibrosis: The Effects of Pseudomonas Aeruginosa and Potential Modifier Genes

* 01-H-0122:
Collection and Storage of Umbilical Cord Hematopoietic Stem Cells for Sickle Cell Disease Therapy

* 01-EI-0046:
Evaluation and Treatment of Corneal and External Diseases and Anterior Segment Disorders

* 01-DK-0247:
Treatment of Chronic Delta Hepatitis with Pegylated Interferon

* 01-DK-0088:
Determining the Prevalence and Prognosis of Secondary Pulmonary Hypertension in Adult Patients with Sickle Cell Anemia

* 01-DK-0062:
Genetic Analysis of Familial Keloids

* 01-DK-0053:
Permeability Factor in Focal Segmental Glomerulosclerosis

* 01-DC-0230:
Studies of Deficits in the Sense of Taste

* 01-DC-0229:
Genetic Analysis of Hereditary Disorders of Hearing and Balance

* 01-DC-0228:
Clinical and Molecular Analysis of Enlarged Vestibular Aqueducts

* 01-DC-0099:
Evaluation for NIDCD Head & Neck Surgery Branch Clinical Research Protocols

* 01-D-0184:
Evaluation and Treatment of Bone and Mineral Disorders

* 01-CH-0086:
A Combination Therapy with Cystagon and N-Acetylcysteine for INCL Patients

* 01-CC-0231:
A Prospective Study of Transfusion-Transmitted Infections

* 01-CC-0045:
Studies of Phlebotomy Therapy in Hereditary Hemochromatosis

* 01-C-0158:
Protocol to Assess Vascularity in Kaposi's Sarcoma Lesions Utilizing Non-Invasive Imaging Techniques

* 01-C-0157:
Eligibility Screening and Tissue Procurement for the National Cancer Institute (NCI), Pediatric Oncology Branch (POB) Clinical Research Protocols

* 01-C-0144:
Surveillance of Invasive Fungal Infections in Bone Marrow/Stem Cell and Solid Organ Transplantation Recipients and Other Immunocompromised Patients: A Prospective Study

* 01-C-0129:
Eligibility Screening and Tissue Procurement for the National Cancer Institute (NCI) Center for Cancer Research (CCR) Clinical Protocols

* 01-C-0125:
Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies

* 01-C-0104:
A Phase I Study of Concomitant Therapy with Proteasome Inhibitor PS-341 and Radiation in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

* 01-C-0070:
Evaluation of the Natural History of Patients with Tumors of the Central Nervous System

* 01-C-0038:
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples from Patients with HIV Infection, KSHV Infection, Viral-related Pre-malignant Lesions, and/or Cancer

* 01-C-0030:
Short-Course EPOCH-Rituximab for Untreated CD-20+ HIV-Associated Lymphomas

* 01-AR-0227:
Natural History of Rheumatic Disease in Minority Communities

* 00-NR-0200:
Neurotropin for Acute Dental Pain and for Chronic Neuropathic Pain

* 00-N-0158:
Trial of Intracerebral Infusion in Patients with Medically Intractable Epilepsy

* 00-N-0095:
Brain Activation During Developmental Speech Production and Speech Perception

* 00-N-0089:
Genetic Analysis of the Chiari I Malformation

* 00-N-0082:
Characterization of Brain Activation at 1.5 and 3.0 Tesla Using Perfusion Images and Blood Oxygen Level Dependent Images

* 00-N-0057:
Positron Emission Tomography Imaging of Activation-Induced Signal Transduction in Human Brain

* 00-N-0043:
Clinical and Molecular Manifestations of Inherited Neurological Disorders

* 00-M-0198:
The Phenomenology and Neurophysiology of Affective Dysregulation in Children and Adolescents with Bipolar Disorder

* 00-M-0177:
Transcranial Magnetic Stimulation Studies of Visual Attention

* 00-M-0103:
The Treatment of Menstrually-Related Mood Disorders with Continuous Gonadal Steroid Replacement

* 00-M-0085:
Structural and Functional Imaging of Neuropsychiatric Patients and Normal Volunteers with 3.0 Tesla MRI and Magnetoencephalography

* 00-I-0159:
Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection (Job) Syndrome

* 00-I-0099:
Langherhans' Cell Function and Inflammatory Responses in Skin of Normal Volunteers and Patients with Helminth Infections Using the Suction Blister Technique

* 00-HG-0209:
Molecular and Clinical Studies of Primary Immunodeficiency Diseases

* 00-HG-0153:
Investigations into Chediak-Higashi Syndrome and Related Disorders

* 00-HG-0141:
Clinical, Biochemical, and Molecular Investigations into Alkaptonuria

* 00-HG-0058:
Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD)

* 00-H-0051:
Cutaneous Tumorigenesis in Patients with Tuberous Sclerosis

* 00-H-0029:
A Pilot Study of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) in Patients with Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia

* 00-EI-0135:
Study of Association of Serum Factors with Diabetic Retinopathy

* 00-DK-0221:
Evaluation of the Immune Response in Humans After Exposure to Hepatitis C Virus

* 00-DK-0125:
Immunogenetics of Hepatitis C Virus Infection

* 00-DK-0107:
Search for Novel Methods to Detect Acute Renal Failure

* 00-DC-0176:
Genetic Studies of Tune Deafness

* 00-DC-0073:
Identification of Hereditary Auditory Processing Deficits

* 00-CH-0219:
Turner Syndrome: Genotype and Phenotype

* 00-CH-0189:
FSH-Stimulated Inhibin B as a Marker for Early Ovarian Insufficiency

* 00-CH-0180:
Endocrine Studies in Health and Disease

* 00-CH-0160:
Clinical and Molecular Analysis of ACTH-Independent Steroid Hormone Production in Adrenocortical Tissue

* 00-CH-0136:
A Trial of Pamidronate in Children with Osteogenesis Imperfecta

* 00-CH-0127:
Evaluation of Patients with Endocrine-Related Conditions

* 00-CH-0093:
Diagnosis, Pathophysiology, and Molecular Biology of Pheochromocytoma

* 00-CH-0035:
The Development of Categorization

* 00-CC-0165:
Filgrastim-Mobilized Peripheral Blood Stem Cells for Primary Allogeneic Transplantation Using Unrelated Donors Participating in the National Marrow Donor Program (NMDP)

* 00-C-0181:
Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols

* 00-C-0121:
A Phase I Investigation of IL-12/Pulse IL-2 in Adults with Advanced Solid Tumors

* 00-C-0078:
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples from Patients with Cancer

* 00-C-0074:
Evaluation of Late Effects and Natural History of Disease in Patients Treated with Radiotherapy

* 00-C-0069:
Phase II Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) with Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-Fluorouracil for Peritoneal Carcinomatosis

* 00-C-0030:
A Phase I/II Study of the Efficacy and Toxicity of Humanized Anti-Tac (Zenapax™ (Trademark)) in the Therapy of Tac-Expressing Adult T-Cell Leukemia

* 00-AR-0222:
Studies of the Pathogenesis and Natural History of Arthritis and Related Conditions

* 99-N-0178:
Feasibility of Neuromuscular Stimulation for Laryngeal Elevation During Swallowing

* 99-N-0045:
Study of Abnormal Acquired and Genetic Coagulation Factors in Children with Porencephaly and Stroke

* 99-N-0009:
Sensory Function in Idiopathic Voice Disorders

* 99-M-0172:
Integrating EEG/MEG and fMRI: Activity Correlation Between Frontal and Temporal Lobe Structures in Schizophrenic Patients, Their Siblings and Unrelated Normal Volunteers

* 99-I-0084:
To Develop a New Technique to Predict the Occurrence of Pneumocystis Pneumonia, Track its Epidemiology, Diagnose Acute Disease, and Predict and Monitor the Response to Various Therapeutic Agents

* 99-H-0076:
Fiberoptic Bronchoscopy in Patients with Asthma

* 99-H-0064:
Exploratory Study of Non-Myeloablative Allogeneic Stem Cell Transplantation and Donor Lymphocyte Infusions for Metastatic Neoplasms Refractory to Standard Therapy

* 99-H-0050:
Non-myeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematologic Malignancies in High Risk Patients and in Patients with Debilitating Hematologic Diseases

* 99-H-0037:
Apheresis of Family Members of Patients Undergoing Allogeneic Bone Marrow Transplantation. A Pre-Clinical Study of Selective Depletion of Donor Lymphocytes to Prevent Acute Graft-Versus-Host Disease

* 99-DK-0119:
Monitoring for Donor-Specific Hyporesponsiveness Following Renal and Pancreatic Allotransplantation

* 99-DK-0002:
Heart Disease Risk Factors in African Americans

* 99-D-0070:
Natural History of Salivary Gland Dysfunction and Sjogren's Syndrome

* 99-CH-0103:
Evaluation of Women with Endocrine and Reproductive-Related Conditions

* 99-CH-0055:
New Imaging Modalities in the Evaluation of Patients with Ectopic Cushing Syndrome

* 99-CC-0168:
Collection and Distribution of Blood Components from Healthy Donors for In Vitro Research Use

* 99-CC-0163:
Functional and Metabolic Imaging Using Magnetic Resonance at 3.0 Tesla

* 99-C-0158:
Treatment of Patients with Metastatic Melanoma Using Cloned Lymphocytes Following the Administration of a Non-Myeloablative but Lymphocyte Depleting Regimen

* 99-C-0128:
Evaluation for NCI Surgery Branch Clinical Research Protocols

* 99-C-0099:
Examination of Clinical and Laboratory Abnormalities in Patients with Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy

* 99-C-0025:
The Use of Radiofrequency Ablation to Treat Hepatic Neoplasms

* 99-AR-0004:
Molecular Basis of Primary Immunodeficiencies

* 98-N-0047:
Immuno-Virological Evaluation of Human T Cell Leukemia Virus Type-1 Associated Myelopathy (HAM/TSP)

* 98-I-0070:
Magnetic Resonance Imaging to Study Avascular Necrosis in HIV-Infected Subjects

* 98-I-0027:
The Characterization of CD34+ Derived Mast Cell Precursors Mobilized by Administration of Granulocyte Colony Stimulating Factor

* 98-HG-0249:
Genetic Analysis of Brain Disorders

* 98-H-0062:
Role of Exotoxins in the Pathogenesis of Pseudomonas Aeruginosa

* 98-EI-0085:
Screening Study for the Evaluation and Diagnosis of Potential Research Subjects with Ocular Inflammatory or Immunologic Diseases

* 98-D-0145:
Screening and Natural History of Patients with Polyostotic Fibrous Dysplasia and the McCune-Albright Syndrome

* 98-D-0116:
Spatial Organization of Viridans Streptococci in Oral Biofilms

* 98-CH-0155:
Categorization Based on Motion-Carried Information in Infancy

* 98-CH-0081:
Clinical and Basic Investigations into Smith-Lemli-Opitz Syndrome

* 98-CC-0090:
Evaluation of Hematologic Patients - Training Protocol

* 98-CC-0019:
Normal Volunteer Scanning on MR

* 98-C-0037:
Evaluation, Treatment, and Natural History of Children with Cancer

* 98-AA-0056:
Functional Neuroanatomy of Positive and Negative Affect in Alcoholics and Non-Alcoholics

* 98-AA-0009:
Screening Evaluation for NIAAA Protocols

* 97-N-0070:
Training Protocol for Various Sleep Disorders in Patients with Neurological Disorders

* 97-I-0191:
Studies of Lymphocyte Kinetics Using Stable Isotopes

* 97-I-0096:
Evaluation, Treatment, and Monitoring of Patients With Known or Suspected Parasitic Infection

* 97-HG-0192:
Genetic Studies in the Amish and Mennonites

* 97-HG-0085:
Therapeutic Clinical Trial of Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome

* 97-H-0196:
A Phase II Study of HLA-Matched Peripheral Blood Stem Cell Transplantation for Metastatic Renal Cell Carcinoma as Adoptive Allogeneic Immunotherapy

* 97-H-0154:
High-Dose Cyclophosphamide with CD34+ Selected Autologous Hematopoietic Cell Support for Treatment of Refractory Chronic Autoimmune Thrombocytopenia

* 97-H-0061:
Evaluation and Treatment of Pulmonary Patients not Participating in Research (Training Protocol)

* 97-H-0041:
Screening Protocol for Subjects Being Evaluated for Hematology Branch Protocols

* 97-H-0022:
Segmental Bronchoalveolar Lavage

* 97-DC-0180:
Genetic Analysis of Human Hereditary Hearing Impairment

* 97-DC-0057:
Non-Parametric and Parametric Linkage Studies of Stuttering

* 97-D-0055:
Studies on Tissues from Patients with Fibrous Dysplasia of Bone/McCune-Albright Syndrome and Other Disorders of Calcified Tissues

* 97-CH-0076:
A Clinical and Genetic Investigation of Pituitary Tumors and Related Hypothalmic Disorders

* 97-CH-0064:
Evaluation and Intervention for Ambulation, Basilar Invagination, and Secondary Effects of Osteogenesis Imperfecta

* 97-C-0178:
Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): DNA Microarray Gene Expression Analysis

* 97-C-0147:
Collection of Serum and Tissue Samples from Patients with Biopsy-Proved or Suspected Malignant Disease

* 97-C-0143:
Investigation of the Human Immune Response and HTLV-1 Infection

* 97-C-0110:
Phase I/II Study of Tac-Expressing Malignancies Other than Adult T-Cell Leukemia (ATL) with Yttrium-90 Radiolabeled Humanized Anti-Tac and Calcium-DTPA

* 97-C-0093:
A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients with Primary and Metastatic Brain Tumors

* 97-C-0028:
Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers

* 96-N-0089:
Characteristics of Idiopathic Familial Voice Disorders

* 96-N-0088:
Characteristics of Idiopathic Familial Speech Disorders

* 96-M-0124:
Genetics of Obsessive-Compulsive Disorder: A Collaborative Study

* 96-I-0129:
Evaluation and Long Term Follow-up of Patients with Allergic and Inflammatory Disorders

* 96-I-0085:
Genetic Studies of the X-Linked Lymphoproliferative Disease

* 96-I-0052:
A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients with Suspected Chronic Lyme Infection and Selected Control Populations

* 96-H-0100:
Role of Genetic Factors in the Pathogenesis of Lung Disease

* 96-H-0049:
Use of Granulocyte Colony Stimulating Factor (G-CSF) Mobilized Leukapheresis Collections from Normal Volunteers to Develop Improved Methods of Stem Cell and Lymphocyte Selection for Allogeneic Transplantation

* 96-CH-0101:
Population Differences in the Insulin Sensitivity, Resting Energy Expenditure, and Body Composition of Overweight Children and Children of Overweight Parents

* 96-C-0102:
Evaluation and Treatment of Subjects with Dermatologic Diseases

* 96-C-0097:
The Acquisition of Blood and Skin Samples from Patient Volunteers to Support Research Activities on Dermatologic and Other Diseases

* 96-C-0071:
Follow-up for Patients Previously Enrolled on the Center for Cancer Research Protocols

* 95-M-0150:
A Neurobiological Investigation of Patients with Schizophrenia Spectrum Disorders and Their Siblings

* 95-M-0097:
An Endocrine Model For Postpartum Mood Disorders

* 95-I-0072:
Clinical, Virologic, and Immunologic Evaluation and Monitoring of Patients with Known or Suspected HIV Infection

* 95-I-0066:
Genetic Analysis of Immune Disorders

* 95-I-0027:
Virologic and Immunologic Evaluation of Lymph Node, Tonsillar, and Intestinal Biopsies, and Bronchoalveolar Lavage Fluid

* 95-HG-0193:
Clinical and Basic Investigations into Hermansky-Pudlak Syndrome

* 95-HG-0165:
Outcomes of Education and Counseling for HNPCC Testing

* 95-HG-0158:
Genetic Analysis of Hereditary Prostate Cancer

* 95-H-0186:
Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)

* 95-H-0047:
Evaluation of Patients with Heart Disease Not Eligible for Research Protocols

* 95-CH-0110:
Endometrial Mediators of Gonadal Steroid Action

* 95-CH-0059:
Definition of the Genotype and Clinical Phenotype of Primary Pigmented Nodular Adrenocortical Disease (PPNAD), Carney Complex, Peutz-Jeghers Syndrome and Related Conditions

* 95-CC-0123:
Evaluation of Healthy Volunteer Marrow Donors Participating in the National Marrow Donor Program (NMDP)

* 94-I-0079:
Eosinophil Activation and Function in Parasitic Infections and Other Conditions with Increased Tissue or Peripheral Blood Eosinophilia in Humans

* 94-I-0073:
Recruitment of Peripheral Blood Hematopoietic Progenitors by Granulocyte Colony Stimulating Factor (G-CSF)

* 94-HG-0193:
Clinical and Genetic Studies of Cogenital Anomaly Syndromes

* 94-HG-0132:
The Phenotype and Etiology of Proteus Syndrome

* 94-H-0010:
Evaluation, Treatment and Training Protocol for Patients with Bone Marrow Failure States, Isolated or Multilineage Cytopenias, Metastatic Solid Tumors, or Hematologic Malignancies

* 94-E-0165:
Studies in the Natural History and Pathogenesis of Childhood-Onset and Adult-Onset Idiopathic Inflammatory Myopathies

* 94-DK-0133:
Genetic Markers for Focal Segmental Glomerulosclerosis

* 94-DK-0127:
Pathogenesis of Glomerulosclerosis

* 94-D-0188:
Bone Regeneration Using Bone Marrow Stromal Cells

* 94-D-0018:
Salivary Evaluation in Normal Volunteers

* 94-C-0074:
Treatment and Natural History Study of Lymphomatoid Granulomatosis

* 94-AR-0105:
Genetics and Pathophysiology of Familial Mediterranean Fever and Related Disorders

* 94-AR-0066:
Studies of the Pathogenesis and Natural History of Systemic Lupus Erythematosus (SLE)

* 93-N-0202:
Diagnosis and Natural History Protocol for Patients with Different Neurological Conditions

* 93-M-0170:
Regional Cerebral Blood Flow Studies of Object Perception, Identification, Localization, and Memory

* 93-I-0119:
Detection and Characterization of Host Defense Defects

* 93-I-0106:
Cryptococcosis in Previously Normal Adults

* 93-I-0086:
Evaluation and Long Term Follow Up of Patients with Acute or Chronic Inflammatory Disorders

* 93-I-0063:
Study of the Immunopathogenesis, Natural History, and Genetics of Autoimmune Lymphoproliferative Syndrome (ALPS) Associated with an Expansion of CD4-8-/TCR alpha/beta+ T Cells and Defective Lymphocyte Apoptosis

* 93-I-0057:
Apheresis Procedures to Obtain Plasma or Leukocytes for In Vitro Studies

* 93-DK-0127:
Family Studies in Metabolic Diseases and Mineral Metabolism

* 93-C-0133:
Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Patients with Aggressive Non-Hodgkin's Lymphoma

* 92-N-0226:
Establishing the Physiology of Syringomyelia

* 92-M-0174:
The Central Nervous System Effects of Pharmacologically Induced Hypogonadotropic Hypogonadism with and without Estrogen and Progesterone Replacement

* 92-I-0125:
A Study of Viral Burden in Peripheral Blood versus Lymphoid and Bone Marrow Tissue in Human Immunodeficiency Virus Infected Individuals

* 92-H-0189:
Evaluation of Patients with Known or Suspected Heart Disease (Screening Protocol)

* 92-EI-0113:
Immunopathology and Molecular Pathology of Ocular Diseases in Humans

* 92-DK-0156:
Studies of Immunologically-Mediated Kidney Diseases

* 92-DC-0178:
Functional Neuroimaging Studies of Speech Motor Control and Language Processing

* 92-CH-0223:
Autoimmune Premature Ovarian Failure: A Controlled Trial of Alternate-Day Prednisone Therapy

* 92-CH-0034:
Studies of Growth Deficiency and Growth Hormone Treatment in Children with Osteogenesis Imperfecta Types III and IV

* 92-CH-0011:
Treatment of Hypoparathyroidism with Synthetic Human Parathyroid Hormone 1-34

* 92-C-0094:
Continuing Treatment for Children and Adults in the Center for Cancer Research

* 91-M-0230:
Mechanisms of Individual Variation of Dextroamphetamine Effects in Normal Human Subjects

* 91-M-0124:
Structural and Functional Imaging of Neuropsychiatric Patients and Normal Volunteers with 1.5 Tesla MRI

* 91-I-0140:
Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Reproductive Fluids in HIV-Infected and HIV-Uninfected Volunteers

* 91-DK-0085:
Studies of Hyperparathyroidism and Related Disorders

* 91-DK-0066:
Fasting Hypoglycemia: Diagnosis and Treatment

* 91-CH-0127:
Ovarian Follicle Function in Patients with Premature Ovarian Failure

* 91-CC-0117:
Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection in a Blood Donor Population

* 91-AR-0196:
Studies on the Natural History and Pathogenesis of Polymyositis, Dermatomyositis, and Related Diseases

* 90-M-0142:
Brain Procurement for the Neuropathology Section, CBDB

* 90-M-0088:
The Treatment of Menstrually-Related Mood Disorders with the Gonadotropin Releasing Hormone (GnRH) Agonist, Depot Leuprolide Acetate (Lupron)

* 90-M-0014:
Studies of Frontal Lobe Function During Cognitive Stimulation as Measured with Oxygen-15 Water Positron Emission Tomography in Normal Subjects and Patients with Neuropsychiatric Disorders

* 90-I-0120:
Comparison of Inflammatory Responses in Normal Volunteers and Patients with Abnormal Phagocyte Function Using the Suction Blister Technique

* 90-CH-0149:
Early Copper Histidine Therapy in Menkes Disease

* 90-CC-0168:
A Rigid Body Data Base on Human Movement

* 89-N-0045:
Evaluation of Progression in Multiple Sclerosis by Magnetic Resonance Imaging (MRI)

* 89-M-0160:
Inpatient Evaluation of Neuropsychiatric Patients

* 89-M-0006:
Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Controls

* 89-I-0174:
Study of Patients with Known or Suspected Infection with Strongyloides Stercoralis

* 89-I-0158:
Studies of Immune Regulation in Patients with Common Variable Immunodeficiency and Related Humoral Immunodeficiency Syndromes

* 89-DK-0173:
Studies of States with Resistance to Vitamin D and Parathyroid Hormone

* 89-DK-0152:
Determination of Glomerular Filtration Rate, Effective Renal Plasma Flow and Glomerular Capillary Wall Permselectivity

* 89-C-0086:
Clinical Manifestations and Molecular Bases of Heritable Urologic Malignant Disorders

* 88-M-0131:
The Evaluation of Women with Perimenopause-Related Mood and Behavioral Disorders

* 88-I-0083:
Host Response to Infection and Treatment in the Filarial Diseases of Humans

* 88-CH-0032:
Specificity of Mother-Infant Interaction: The Influence of Maternal Age, Employment Status, and Parenthood Status

* 87-I-0163:
Apheresis Procedures to Obtain Plasma or Leukocytes for In Vitro Studies

* 87-DK-0029:
Diagnosis and Treatment of Patients with Cystic Fibrosis and Other Disorders of the Respiratory System and Pancreas

* 87-CC-0091:
Nuclear Magnetic Resonance Imaging/Spectroscopy at 1.5 and 3.0 Tesla

* 86-HG-0096:
Studies of Genetic Heterogeneity in Patients with Lysosomal Storage Disorders

* 86-H-0088:
Lymphocytapheresis of Patients with Pancytopenia

* 86-EI-0062:
Trial of Topical Cysteamine in the Treatment of Corneal Cystine Crystal Accumulation in Cystinosis

* 85-N-0195:
A Training Protocol for the use of Botulinum Toxin in the Treatment of Neurological Disorders

* 85-I-0127:
Treatment of Patients with Cysticercosis with Praziquantel, Albendazole and Other Novel Treatment Modalities

* 85-DK-0082:
Acromegaly Treatment and Natural History

* 84-M-0050:
Biochemical, Physiological, and Psychological Measures in Normal Controls and Relatives of Psychiatric Patients

* 84-D-0056:
Evaluation and Treatment of Salivary Gland Dysfunction

* 84-CH-0169:
Endocrine Studies of Healthy Children

* 83-C-0022:
Psychological Benefits of a Normalized Camping Experience for Children with Cancer

* 82-I-0183:
Study of the Immune Regulation of Idiopathic Inflammatory Bowel Diseases: Crohn's Disease, Ulcerative Colitis, and Other Inflammatory Conditions of the Gut

* 82-H-0032:
Comprehensive Evaluation of the Etiology and Pathogenesis of Chronic Lung Disease (Screening Protocol)

* 81-N-0010:
Regional Cerebral Utilization of Glucose in Patients with a Diagnosis of Frontal Lobe Dementia, Atypical Parkinsonian Disorder, and Other Basal Ganglia Disorders

* 81-M-0126:
The Phenomenology and Biophysiology of Menstrually Regulated Mood and Behavioral Disorders

* 81-I-0164:
Apheresis Procedures to Obtain Plasma or Lymphocytes for In Vitro Studies

* 80-M-0083:
Bipolar Genetics: A Collaborative Study

* 79-H-0100:
Teaching Protocol for the Evaluation of Plasma Lipoproteins

* 78-I-0023:
Diagnosis and Management of Inflammatory and Infectious Diseases

* 78-HG-0093:
Use of Cysteamine in the Treatment of Cystinosis

* 78-C-0039:
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer

* 77-I-0094:
Study of Patients with Parasitic Infections of the Gastrointestinal Tract

* 77-DK-0096:
Studies on Thyroid Nodules and Thyroid Cancer

* 77-DK-0002:
Evaluation of Patients with Thyroid Function Disorders

* 76-N-0021:
Combined Clinical, Immunological and Virological Assessment of Patients with Multiple Sclerosis (MS)

* 76-HG-0238:
Diagnosis and Treatment of Patients with Inborn Errors of Metabolism

* 76-H-0051:
Lipoprotein Metabolism in Normal Volunteers and Hyperlipoproteinemic Patients

* 76-DK-0006:
Studies of Molecular Genetics of Insulin Secretion, Insulin Action, and Diabetes Mellitus

Active Followup, Protocols NOT Recruiting New Patients 

* 08-H-0210:
Long Term Follow Up of Children and Adolescents Diagnosed with Hypertrophic Cardiomyopathy: Identification of Risk Factors that Predict Arrhythmia Events

* 08-CC-0024:
Immunologic and Virologic Response in HIV Infected HLA-B*57 Progressors after Infusion of Lymphocytes from HIV Infected HLA-B*57 "Elite" Long-Term-Nonprogressors

* 08-C-0148:
A Pilot Study of Imatinib Mesylate in Children and Adults with Sclerotic Skin Changes of Chronic Graft-Versus-Host Disease

* 08-C-0056:
Phase II Study of Metastatic Melanoma Using Lymphodepleting Conditioning Followed by Infusion of Anti-MART-1 F5 TCR-Gene Engineered Lymphocytes and ALVAC Virus Immunization

* 08-C-0055:
Phase II Study of Metastatic Melanoma Using Lymphodepleting Conditioning Followed by Infusion of Anti-gp100:154-162 TCR-Gene Engineered Lymphocytes and ALVAC Virus Immunization

* 08-AR-0008:
Insulin Resistance and Atherosclerosis in a Sample of Women with Systemic Lupus Erythematosus

* 07-N-0139:
Cross-Validating NIRS with fMRI

* 07-M-0129:
PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using (11C)PBR28 in HIV-Seropositive Patients with (MCMD)

* 07-M-0035:
PET Whole Body Imaging Using a Peripheral Benzodiazepine Receptor Ligand [C-11]PBR28

* 07-I-0172:
A Phase I Open-Label Study of the Safety and Immunogenicity of a Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for the Influenza Virus H5 Hemagglutinin Protein Administered Intradermally in Healthy Adults

* 07-I-0155:
A Ph I/IIa Rand Placebo Ctrl, S-Blind Multictr Dose-Esc Study of SC Intermittent Interleukin-7 CYT107 in Chronically HIV-Infected Pts with CD4 T Lymphocyte Counts 101-400 Cells-/mm(3) and Plasma HIV RNA Less Than 50 copies/mL After at Least 12 M of HAART

* 07-I-0083:
Phase I Study of the Safety and Immunogenicity of AMA1-C1/Alhydrogel + CPG 7909, an Asexual Blood Stage Vaccine for Plasmodium Falciparum Malaria

* 07-HG-0204:
Deliberation with and without Attention: Can We Enhance Informed Choices about Invasive Prenatal Testing? A Proof of Principle Study

* 07-H-0186:
Genes Causing Congenital Ebstein's Anomaly

* 07-H-0157:
Suburban/NHLBI Cardiovascular Disease Screening Protocol

* 07-H-0124:
Pilot Study for the Development of Transient Forearm Endothelial Dysfunction

* 07-EI-0213:
LI/National Eye Institute Repository

* 07-D-0016:
Effects of Calcitriol vs. PTH Replacement Therapy on Bone in Patients with Hypoparathyroidism

* 07-CH-0193:
Use of GnRH Antagonist to Preserve Ovarian Function in Women Undergoing Chemotherapy

* 07-CH-0169:
Noninvasive Optical Imaging of the Effects of External Spectral Filters on Macular Autofluorescence in Pseudophakic Eyes

* 07-CC-0015:
Exploring Decision Making of Hispanics and African Americans with HIV/AIDS Participating in Clinical Trials

* 07-C-0138:
A Phase II Trial of GW786034 (Pazopanib) in Subjects with Recurrent Glioblastoma

* 07-C-0028:
Screening of Mannose-Binding Lectin (MBL) Status in Pediatric Hematology/Oncology Patients

* 07-C-0027:
A Multi-Center Study of the Safety, Tolerability, Pharmacokinetics, and Dose Escalation of Intravenous Recombinant Human Mannose-Binding-Lectin (rhMBL) in MBL Deficient Pediatric Hematology/Oncology Patients with Fever and Neutropenia

* 06-N-0139:
Treatment for Psychogenic Movement Disorders

* 06-N-0113:
Phase II Clinical Trial to Examine the Efficacy and Safety of Dutasteride in Patients with Kennedy's Disease (Spinal and Bulbar Muscular Atrophy)

* 06-N-0097:
Dose-Response Study of Modulation of Gene Expression in Peripheral Blood Mononuclear Cells by Atorvastatin

* 06-N-0096:
Testing Objective Measures of Motor Impairment in Early Parkinson's Disease

* 06-N-0067:
Direct Current Brain Polarization for Apraxia in Corticobasal Syndrome

* 06-M-0238:
An Investigation of the Efficacy of Mercury Chelation as a Treatment for Autism Spectrum Disorder

* 06-I-0180:
Evaluation of Alternative Oseltamivir (Tamiflu[R]) Dosing Strategies for Use during Influenza Prophylaxis

* 06-I-0149:
VRC 011: A Phase I Clinical Trial of Intramuscular, Subcutaneous and Intradermal Administration of an HIV-1 Multiclade DNA Vaccine, VRC-HIVDNA016-00-VP, and an HIV-1 Multiclade Adenoviral Vector Vaccine,VRC-HIVADV014-00-VP, in Uninfected Adult Volunteer

* 06-I-0105:
A Phase I Double-Blind, Placebo-Controlled, Dose-Escalating Study to Evaluate the Safety and Tolerability of Intravenous Peramivir in Healthy Subjects

* 06-I-0056:
VRC101: A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Prime-Boost HIV-1 Vaccination Schedule of a 6-Plasmid Multiclade HIV-1 DNA Vaccine, VRC-HIVDNA016-00-VP, Followed by a Recombinant Multiclade Adenoviral Vector HIV Vaccine

* 06-HG-0148:
Identity, Ancestry and Genetics: Patients' Perspectives

* 06-HG-0143:
Using Virtual Reality to Test Communication Strategies for Genomic Concepts

* 06-H-0220:
Long-Term, Open-Label, Multicenter, Extension Study of Bosentan in Patients with Pulmonary Hypertension Associated with Sickle Cell Disease Completing a Double-Blind ASSET Study (AC-052-368 or AC 052-369)

* 06-H-0208:
Cardiovascular Magnetic Resonance Imaging of Pediatric Normal Volunteers

* 06-H-0168:
An Open-Label, Baseline-Controlled Study of the Safety and Efficacy of SeeMore (EVP 1001-1 Injection) in Heart Patients

* 06-H-0124:
Randomized, Placebo-Controlled, Double-Blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Bosentan in Patients with Symptomatic Pulmonary Hypertension Associated with Sickle Cell Disease (ASSET 2)

* 06-H-0123:
Randomized, Placebo-Controlled, Double-Blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Bosentan in Patients with Symptomatic Pulmonary Arterial Hypertension Associated with Sickle Cell Disease (ASSET 1)

* 06-H-0122:
Mechanism and Vascular Effects of Endothelial Progenitor Cell Mobilization in Patients with Coronary Artery Disease Undergoing Cardiac Rehabilitation

* 06-H-0082:
Telomere Repair Gene Mutations in Inflammatory Bowel Disease

* 06-H-0062:
Safety of WT1 and PR1 Peptide Vaccination for Patients with Myeloid Malignancies

* 06-H-0018:
Effect of Regular Exercise on Vascular Function and Cardiovascular Risk in a Sedentary Work Force: The NHLBI "Keep the Beat" Program

* 06-EI-0116:
A Phase II Study of OT-551 Antioxidant Eye Drop in Participants with Bilateral Geographic Atrophy Associated with Age-Related Macular Degeneration

* 06-D-0188:
Physiologic Regulation of FGF-23

* 06-D-0144:
Diagnosis, Evaluation and Treatment of Patients in Need of Third Molar Removal

* 06-CH-0201:
Effect of Transdermal Estradiol Replacement Therapy on Ovulation Rate in Women with Premature Ovarian Failure: A Randomized, Placebo-Controlled Trial

* 06-CH-0091:
The Effects of Endometriosis on Bone Mineral Density

* 06-CH-0090:
Evaluation of Whether the Selective Progesterone Receptor Modulator CDB-2914 Can Shrink Leiomyomata

* 06-CH-0070:
Salmonella Typhi Vi O-Acetyl Pectin-rEPA Conjugate Vaccine, Phase 1 Trial in Adults at NIH CC

* 06-CH-0039:
Pilot Program for Targeted Prevention of Adolescent Weight Gain

* 06-C-0227:
Phase I Trial of Intravenous Fenretinide (4-HPR) for Patients with Hematologic Malignancies

* 06-C-0226:
A Phase I Pharmacokinetic and Pharmacodynamic Study of Temsirolimus (CCI-779) in Patients with Advanced Malignancies and Normal and Impaired Liver Function: An NCI Organ Dysfunction Working Group Study

* 06-C-0200:
A Phase 1 Study of the Safety and Efficacy of GC1008: A Human Anti-Transforming Growth Factor-Beta (TGFBeta) Monoclonal Antibody in Patients with Advanced Renal Cell Carcinoma or Malignant Melanoma

* 06-C-0196:
A Study of the Safety, Tolerability, and Pharmacokinetics of MORAb-009, a Chimeric Monoclonal Antibody, in Subjects with Advanced Mesothelin-Expressing Tumors

* 06-C-0172:
A Phase 0 Pharmacokinetic, Pharmacodynamic Study of ABT-888, an Inhibitor of Poly (ADP-ribose) Polymerase (PARP), in Refractory Solid Tumors and Lymphoid Malignancies

* 06-C-0151:
Phase I Study of CDDO in Solid Tumors and Lymphomas

* 06-C-0146:
Phase II Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, in Children and Young Adults with Refractory Solid Tumors

* 06-C-0137:
Phase II Evaluation of RFT5-dgA in Patients with Metastatic Melanoma

* 06-C-0136:
Phase II Study Using a Myeloablative Lymphocyte Depleting Regimen of Chemotherapy and Intensive Total Body Irradiation Followed by Infusion of Tumor Reactive Lymphocytes and Reconstitution with CD34+ Stem Cells in Metastatic Melanoma

* 06-C-0089:
A Phase II Trial of 06-Benzylguanine and Temozolomide in Pediatric Patients with Recurrent or Progressive High-Grade Gliomas and Recurrent or Progressive Brainstem Tumors

* 06-AA-0129:
NK1 Receptor Antagonism for Treatment of Anxiety and Craving in Anxious Alcohol Dependent Subjects During Early Abstinence

* 05-N-0245:
A Six Month Double-Blind, Placebo-Controlled Phase 2 Clinical Trial to Determine the Safety and Efficacy of Idebenone Administered to Patients with Friedreich's Ataxia

* 05-N-0092:
Clinical Trial Characterizing the Bioavailability of 1-Octanol in Adults with Ethanol-responsive Essential Tremor

* 05-N-0036:
Recombinant Human Interferon Beta-1a in Acute Ischemic Stroke: A Dose Escalation and Safety Study

* 05-N-0018:
The Functional Anatomy of Personality Trait Knowledge: an fMRI Study

* 05-M-0161:
An Investigation of the Antidepressant Efficacy and Safety of an AMPAkine (Org 24448) in Major Depressive Disorder, A Double-Blind, Placebo-Controlled, Randomized Study

* 05-I-0133:
Phase 1 Study of the Safety of Immunization of Naive Individuals with AMA1-C1/Alhydrogel [R], an Asexual Blood-Stage Vaccine for Plasmodium Falciparum Malaria, and the Effect of Immunization on Antigen-specific Memory and Plasma B Cells and T Cells

* 05-I-0108:
A Multicenter, Open-Label, Study of Extracorporeal Photoimmune Therapy with UVADEX in the Treatment of Patients with Moderately Active Crohn's Disease Who Are Refractory or Intolerant to Immunosuppressants and/or Anti-TNF Agents

* 05-I-0065:
A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Effect of Leflunomide on HIV-1 Associated Immune Proliferation In Vivo

* 05-HG-0236:
Pilot Study of the Use of Intravenous Immune Globulin in Hereditary Inclusion Body Myopathy

* 05-HG-0076:
Long-Term Clinical Trial of Nitisinone in Alkaptonuria

* 05-HG-0004:
Clinical Investigations into Hutchison-Gilford Progeria Syndrome

* 05-H-0243:
A Phase I, Open-Label, Multiple-Center, Single-Dose, Dose-Escalating, Safety, Tolerability, Immunogenicity, Pharmacokinetic and Pharmacodynamic Study of GMA161 in Patients with Idiopathic Thrombocytopenic Purpura (ITP)

* 05-H-0163:
Relationship of Diastolic Function and Functional Capacity in Hypertrophic Cardiomyopathy: a Post-Hoc Analysis of Protocols 01-H-0066 and 96-H-0144

* 05-H-0145:
Nitrite as a Marker of Cardiovascular Risk; Development of Novel Biomarkers in Patients with Coronary Artery Disease

* 05-H-0114:
Evaluation of Systemic Nitrite Infusion and Its Effect on Exercise Physiology and Metabolism

* 05-H-0088:
Evaluation of the Mechanism of NO Formation and Pharmacokinetics of Systemic Nitrite Infusion

* 05-H-0016:
Therapeutic Application of Intravascular Nitrite for Sickle Cell Disease

* 05-EI-0002:
A Phase I Clinical Trial to Study the Safety of a Sustained-Release Subconjunctival Cyclosporine Implant for Ocular Graft-vs-Host Disease (GVHD1)

* 05-DC-0238:
Effects of Sleep Deprivation and Recovery Sleep on Speech, Language and Other Higher Cognitive Functions: A Combined EEG-fMRI Study

* 05-D-0051:
Collection of Dental Plaque and Saliva for Studies of Oral Microbial Colonization

* 05-CH-0037:
The Effects of Hydrocortisone, Melatonin, and Placebo on Symptoms of Jet Lag

* 05-CC-0246:
The Evaluation of Focal Contrast-Enhancing Brain Lesions in HIV-Infected Patients

* 05-CC-0093:
The Effect of Animal-Assisted Therapy on Oncology Patients Being Treated for Pain

* 05-CC-0042:
Coupled Joint Proprioception and Multi-Joint Movement in the Lower Extremity: A Pilot Study

* 05-CC-0008:
Revising Employee Benefits for the Sake of Health

* 05-C-0239:
A Phase I Trial and Pharmacokinetic Study of Talabostat (PT-100, VAL-BORO-PRO) in Combination with Temozolomide or Carboplatin in Pediatric Patients with Relapsed or Refractory Solid Tumors Including Brain Tumors

* 05-C-0232:
A Phase I Trial of Peginterferon Alfa-2b (PEG-Intron) for Plexiform Neurofibromas

* 05-C-0231:
A Phase II Study to Evaluate the Efficacy, Safety, and Pharmacodynamics of Lapatinib in Patients with Relapsed or Refractory Inflammatory Breast Cancer

* 05-C-0171:
Phase I Study of BL22, a Recombinant Immunotoxin for Chronic Lymphocytic Leukemia and CD22+ Lymphomas

* 05-C-0167:
Phase I Trial of a PSA based Vaccine and an anti-CTLA-4 Antibody in Adults with Metastatic Androgen Independent Prostrate Cancer

* 05-C-0141:
Phase II Trial of Single Agent Ipilimumab (MDX-010 anti CTLA-4) for Subjects with Locally Advanced or Metastatic Pancreatic Adenocarcinoma

* 05-C-0136:
A Phase I Trial of Enzastaurin (LY317615) in Patients with Recurrent Gliomas

* 05-C-0134:
A Biomarker and Phase II Study of GW572016 in Recurrent Malignant Glioma

* 05-C-0132:
A Phase I Trial of CC-5013 (Lenalidomide) in Pediatric Patients with Recurrent or Refractory Primary CNS Tumors

* 05-C-0031:
Randomized Trial of Patient-Specific Vaccination with Conjugated Follicular Lymphoma-Derived Idiotype with Local GM-CSF in First Complete Remission

* 05-C-0022:
A Phase I Trial of BAY 43-9006 (Sorafenib) and Bevacizumab in Refractory Solid Tumors with Biologic and Proteomic Analysis

* 05-AT-0047:
Effects of Cocoa Consumption on Insulin Sensitivity and Capillary Recruitment in Subjects with Essential Hypertension

* 04-N-0287:
Efficacy of Rituximab in Patients with Stiff Person Syndrome with Anti-GAD Antibodies: A Randomized Placebo-Controlled Trial

* 04-N-0247:
Treatment Study for Frontotemporal Dementia

* 04-N-0207:
An Open Label Clinical Trial of Replagal Enzyme Replacement Therapy In Children With Fabry Disease Who Have Completed Study TKT023

* 04-N-0192:
The Role of the Prefrontal Cortex in Economic Decision-Making in Reciprocal Trust Games Using Functional Hyperscanning Neuroimaging

* 04-N-0153:
Timing of Voluntary Movement in Patients With Tourette Syndrome and Chronic Tic Disorder Using EEG and Surface EMG

* 04-N-0151:
Timing of Voluntary Movement in Patients with Schizophrenia Using EEG and Surface EMG

* 04-N-0150:
Role of Ventral Premotor Cortex in Recovery of Motor Function in Chronic Stroke

* 04-N-0146:
fMRI Study on Mechanism of Rhythm Perception and Generation

* 04-N-0133:
Effects of a T Cell-Depleting Monoclonal Antibody, Alemtuzumab, in Patients with Inclusion Body Myositis: A Pilot Clinicopathological Study

* 04-N-0059:
Sensorimotor Gating Studies in Restless Legs Syndrome

* 04-N-0047:
Role of the Parieto-Frontal Network in Automatic Processing of Visually Presented Objects

* 04-N-0027:
An Open-Label Maintenance Study of the Enzyme Replacement Therapy Replagal® (Registered Trademark) in Patients with Fabry Disease

* 04-N-0019:
Zenapax (daclizumab) Admin to Pts with Multiple Sclerosis (ZAP MS): Effect of Intravenously Admin Humanized Monoclonal Antibody Against the Interleukin-2 Receptor Alpha Subunit (Daclizumab) on Inflammatory Activity in the Central Nervous System

* 04-N-0016:
Non-Invasive Seizure Localization in Patients with Medically Refractory Localization Related Epilepsy: Synchronized MEG-EEG Recordings

* 04-M-0136:
Neurocardiac Control in Major Depression

* 04-I-0289:
Secondary Transplantation Using Moderate Dose Busulfan as Conditioning for a Patient with Partial Reconstitution Post Initial Allogeneic Transplantation

* 04-I-0266:
Collection of Peripheral Blood and Bone Marrow From Healthy Donors for Use in In Vitro Research

* 04-I-0187:
A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Twice-Weekly Peginterferon Alpha 2a and Ribavirin Induction Therapy for Chronic Hepatitis C in Patients who are Coinfected with HIV-1

* 04-I-0176:
Pilot Study of Omalizumab in Eosinophilic Gastroenteritis

* 04-I-0172:
A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Recombinant Multiclade HIV-1 Adenoviral Vector Vaccine, VRC-HIVADV014-00-VP, in Uninfected Adult Volunteers

* 04-I-0158:
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Phase III Study to Evaluate Corticosteroid-Reduction and -Sparing Effects of Mepolizumab 750 mg Intravenous in Subjects with Hypereosinophilic Syndromes (HES), and to evaluate th

* 04-I-0126:
Exhaled Breath Condensate as a Measurement of Airway Inflammation in Children with Asthma

* 04-I-0018:
Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Anti-Retroviral Treatment in HIV Infected Patients with CD4 T-Lymphocyte Count Greater Than 500 Cells/mm(3) Who Have Received Anti-Retroviral

* 04-H-0213:
Cytokine Gene Polymorphisms in Bone Marrow Failure

* 04-H-0198:
A Pilot Trial of an Accelerated Immunization Schedule with ALVAC-pp65 (vCP260) for Inducing CMV-Specific Immunity in Stem Cell Allotransplant Donors and Healthy Volunteers

* 04-H-0112:
Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies - Effect of Peritransplant Cyclosporine on Chimerism

* 04-DK-0193:
Identification and Mechanistic Investigations of Tolerant Kidney Transplant Patients

* 04-DK-0099:
Depletional Induction with Rabbit Anti-Thymocyte Globulin, Followed by Two Approaches Toward Monotherapy Immunosuppression in Kidney Transplant Recipients

* 04-DK-0057:
Renal Transplantation in Recipients with Nephropathic Cystinosis

* 04-CH-0283:
Anthrax Vaccine Clinical Trials

* 04-CC-0184:
Influence of MDR-1 CYP3A4 and CYP3A5 Genotypes/Haplotypes on Sirolimus Pharmacokinetics and Pharmacodynamics in Patients with Renal Transplantation

* 04-CC-0130:
The Effect of a Systemic Oral Care Program on Reducing Exposure to Oropharyngeal Pathogens in Critically III Patients

* 04-CC-0070:
Exploring Patient-Provider Trust among Individuals with End-Stage Renal Disease

* 04-CC-0046:
Citrate Effects and Bone Density Studies in Long-Term Apheresis Donors

* 04-CC-0032:
Atorvastatin Therapy To Improve Endothelial Function in Sickle Cell Disease

* 04-C-0288:
Treatment of Patients with Metastatic Melanoma Using a Transplant of Autologous Lymphocytes Reactive with Tumor Following a Myeloablative Lymphocyte Depleting Regimen of Chemotherapy, Total Body Irradiation and Reconstitution with CD34+ Cells

* 04-C-0280:
Randomized, Crossover, Pharmacokinetic Study of Paclitaxel (Taxol) and ABI-007 (a Cremophor EL-Free, Protein Stabilized, Nanoparticle Paclitaxel) in Patients with Advanced Solid Tumors

* 04-C-0276:
A Pilot Study of a Three Month Intervention for Increasing Physical Activity in Sedentary Women at Risk for Breast Cancer

* 04-C-0263:
A Phase I Dose Escalation Study of Heat Activated Liposome Delivery of Doxorubicin and Radiofrequency Ablation of Primary and Metastatic Tumors of the Liver

* 04-C-0262:
A Phase II Study of BAY 43-9006 (Sorafenib) in Metastatic, Androgen-Independent Prostate Cancer

* 04-C-0259:
Immunization of Patients with Renal Cancer Using HLA-A2 and HLA-A3-Binding Peptides from Fibroblast Growth Factors 5 (FGF-5)

* 04-C-0251:
A Study in Metastatic Melanoma Using a Lymphodepleting Conditioning Followed by Infusion of Anti-MART-1 TCR-Gene Engineered Lymphocytes and Subsequent Peptide Immunization

* 04-C-0246:
An Open Label Pilot Study to Evaluate the Safety and Tolerability of PANVAC-V (Vaccinia) and PANVAC-F (Fowlpox) in Combination with Sargramostim in Adults with Metastatic Carcinoma

* 04-C-0218:
A Phase I Study of17-Dimethylaminoethylamino-17-Demethoxygeldanamycin (17-DMAG) with Evaluation of HSP-90 Client Proteins in Patients with Solid Tumors and Lymphomas

* 04-C-0181:
Treatment of Patients with Metastatic Melanoma by Lymphodepleting Conditioning Followed by Infusion of TCR-Gene Engineered Lymphocytes and Subsequent Fowlpox gp100 Vaccination

* 04-C-0171:
A Prospective Histopathologic Study of Dynamic Contrast Enhanced MRI for Prostate Cancer Delineation and Characterization with the APT-MRI System

* 04-C-0167:
A Pilot Trial of a CEA-TRICOM Based Vaccine and Radiation to Liver Metastasis in Adults with CEA Positive Solid Tumors

* 04-C-0152:
Phase II Study in Metastatic Melanoma Using Lymphocytes Reactive with the gp100 Antigen and Immunization Using a Recombinant rF-gp100P209 Virus Encoding a gp100 Peptide Following a Nonmyeloablative Lymphocyte Depleting Regimen

* 04-C-0141:
A Pilot Phase I Dose Escalation Study of the EGFR Tyrosine Kinase Inhibitor (Iressa) Combined with Paclitaxel (Taxol) and External Beam Radiation Therapy in Patients with Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)

* 04-C-0095:
A Pilot Study of Intensified Lymphodepletion Followed by Autologous Hematopoietic Stem Cell Transplantation in Severe Systemic Lupus Erythematosus

* 04-C-0088:
Levels of Phosphorylated AKT in Patients with Node-Positive Breast Cancer: Correlation with Disease-Free and Overall Survival

* 04-C-0080:
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults with Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas

* 04-C-0044:
A Trial of Exemestane in Postmenopausal Women with DCIS or at High Risk for Invasive Breast Cancer

* 04-C-0031:
Phase I Trial of Medi-507 in CD2-Positive Lymphoproliferative Disease

* 04-AA-0072:
Clinical Trial of the Cannabinoid CB1 Receptor Antagonist, SR141716 (Rimonabant), to Reduce Voluntary Ethanol Drinking in Healthy, Non-Treatment Seeking Individuals Who Consume Between 20 and 50 Drinks Per Week

* 03-N-0286:
Study of Weekly Dosing Regimens of Replagal in Patients with Fabry Disease with Incomplete Clinical Response to Long-Term Therapy

* 03-N-0203:
SMN Levels in Peripheral Blood Samples of SMA Patients and the Effects of Pharmacological Compounds In Vitro

* 03-N-0048:
The Effect of Peripheral Heterotopic Stimulation on Cortical Excitability in Dystonia

* 03-I-0022:
A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA009-00-VP in Uninfected Adult Volunteers

* 03-H-0312:
Dietary Nitrate/Nitrite as Sources of Bioactive Nitric Oxide in Patients with Coronary Artery Disease

* 03-H-0282:
Characterization of Cardiac Function in Patients with Hereditary Hemochromatosis Who Are New York Heart Association Functional Class I

* 03-H-0219:
A Genome-Wide Scan for Quantitative Trait Loci of Hematocrit - A Framingham Study

* 03-H-0201:
Cytokine Gene Polymorphisms in Allotransplant Donors

* 03-H-0193:
A Randomized Trial of a Novel Immunosuppressive Combination of ATG, CsA and Sirolimus (Rapamune) vs a Slow Taper Cyclosporine Regimen in Subjects with Severe Aplastic Anemia

* 03-H-0192:
Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-back for Hematological Malignancies - Effect of Irradiated Donor Lymphocytes on Chimerism

* 03-DK-0245:
Effect of AC2993 (Synthetic Exendin-4) - Administered Alone or in Combination with Daclizumab - On Islet Function in Patients with Type I Diabetes

* 03-DK-0212:
Long-Term Treatment of Nonalcoholic Steatohepatitis With Pioglitazone

* 03-DK-0136:
Low Dose Peginterferon and Ribavirin Therapy for Patients with Chronic Hepatitis C Infected with Genotype 2 or 3

* 03-DK-0132:
The Pathogenesis of Chronic Graft Failure after Kidney Transplantation

* 03-DK-0071:
Sirolimus Therapy in Idiopathic and Lupus Membranous Nephropathy

* 03-CC-0306:
A Phase I/II Randomized, Placebo-Controlled Trial to Assess the Safety and Efficacy of Intravenous Immunoglobulin G (Omr-IgG-am) Containing High Anti-West Nile Virus Antibody Titers in Patients with, or at High Risk for Progression to West Nile Virus(WNV

* 03-CC-0305:
Investigation of the Natural History of West Nile Virus Infection in Patients with Recently Acquired West Nile Fever or Neuroinvasive Disease

* 03-CC-0301:
Health Beliefs and Health Behavior Practices among Minorities with Rheumatic Diseases

* 03-CC-0127:
Evaluation of Potential Synergy of Combining Hydroxyurea with Nitric Oxide Donors on Fetal Hemoglobin Synthesis in Patients with Sickle Cell Anemia

* 03-CC-0091:
Global Initiative to Characterize Differences in Antiretroviral Pharmacokinetics in HIV-Infected Populations

* 03-CC-0052:
Influence of MDR1 Genotype on Indinavir and Saquinavir Pharmacokinetics in Healthy Volunteers

* 03-C-0228:
Characterization of Serum Proteomic Patterns in Neoplastic and Inflammatory Skin Disease

* 03-C-0190:
Trans-Rectal Placement of Prostatic Fiducial Markers Under MR-Guidance in Patients Receiving External Beam Radiotherapy for Prostate Cancer: A Pilot Study

* 03-C-0176:
A Phase I/II Pilot Study of Sequential Vaccinations with rFowlpox-PSA (L155)-TRICOM (PROSTVAC-F/TRICOM) Alone, or in Combination with rVaccinia-PSA (L155)-TRICOM (PROSTVAC-V/TRICOM), and the Role of GM-CSF, in Men with Prostate Cancer

* 03-C-0172:
Randomized Comparison of Peptide Immunization in Patients at High Risk for Recurrence of Melanoma

* 03-C-0162:
Tumor Infiltrating Lymphocytes (TIL Cells) Transduced with an Interleukin-2 (SBIL-2) Gene following the Administration of a Nonmyeloablative But Lymphocyte Depleting Regimen in Metastatic Melanoma

* 03-C-0152:
A Phase I Study of Subcutaneous "CYT 99 007" (Interleukin-7) in Patients with Refractory Non Hematologic Malignancy

* 03-C-0124:
Follow-Up Study of Breast Cancer and Multiple Myeloma Subjects Previously Enrolled in Retroviral Gene Transfer Studies

* 03-C-0096:
PS-341 and PS-341 + Epoch Chemotherapy and Molecular Profiling in Relapsed or Refractory Diffuse Large B-Cell Lymphomas

* 03-C-0085:
A Prospective Random Assignment Trial to Study Operative Debuking and Systemic Chemotherapy with or without Intra-and Peri-Operative Intraperitoneal Chemotherapy for Subjects with Peritoneal Carcinomatosis from Low Grade Gastrointestinal Adenocarcinoma

* 03-C-0084:
Collection of Blood Samples From Pediatric Patients with HIV Infection and Their Family Members

* 03-C-0077:
A Pilot Study of EPOCH-F/R Induction Chemotherapy and Reduced-Intensity, HLA-Matched, Related Allogeneic Hematopoietic Stem Cell Transplantation, with Cyclosporine & Methotrexate GVHD Prophylaxis for Refractory or Relapsed Hematologic Malignancies

* 03-C-0038:
Phase I Study of HeFi-1 in Refractory CD30-Positive Malignancy

* 03-C-0002:
A Phase II Study of Peginterferon Alpha-2B (Peg-Intron(TM)) and Thalidomide in Adults with Recurrent High-Grade Gliomas

* 03-AR-0130:
Genetic Determinants of Ankylosing Spondylitis Severity - Cross Sectional Study

* 02-N-0301:
ReoPro Retavase Reperfusion of Stroke Safety Study-Imaging Evaluation with Computed Tomography (ROSIE-CT)

* 02-N-0221:
Stroke Genomics - A Correlative Study of Stroke Subtypes, Neuroimaging, Therapy and Outcome Measures

* 02-N-0182:
Quantitative fMRI in Children and Adults Using Arterial Spin Tagging Techniques

* 02-N-0175:
Study of Tics in Patients with Tourette's Syndrome and Chronic Motor Tic Disorder with [15O]H2O PET in Awake and in Sleep States

* 02-N-0154:
ReoPro Retavase Reperfusion of Stroke Safety Study - Imaging Evaluation

* 02-N-0069:
Brain Areas Involved in Temporal Linkage of Bilateral Movements

* 02-M-0281:
The Characterization of Childhood Onset Obsessive Compulsive Disorder and the PANDAS Subgroup

* 02-M-0162:
Tryptophan Depletion PET Study in Remitted Depressed Subjects and Healthy Controls, and GABA MRS Study in Remitted and Currently Depressed Subjects and Healthy Controls

* 02-M-0092:
Reward-Related Processes and Brain Function

* 02-M-0036:
A Behavioral and Functional Neuroimaging Study of Inhibitory Motor Control

* 02-H-0265:
Identification of Genes Expressed in Atherosclerotic Plaques

* 02-H-0111:
Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies - Role of Preparative Regimen and T Cell Dose in Graft Rejection and GVHD

* 02-H-0050:
Technical Development of Cardiovascular Magnetic Resonance Imaging

* 02-DK-0065:
Combination of Pegylated Interferon and Ribavirin as Therapy for Patients with Chronic Hepatitis C with and without Renal Disease

* 02-DC-0008:
Assessment of Pre- and Post-Synaptic Dopamine Function in Developmental Stuttering Using 11C-Raclopride and Positron Emission Tomography

* 02-D-0169:
Complex Regional Pain Syndrome Proteomics Study

* 02-CH-0309:
The Diagnostic Performance of Screening Tests for the Diagnosis of Cushing's Syndrome

* 02-CH-0287:
Treatment of Leiomyomata with the Selective Progesterone Receptor Modulator CDB-2914

* 02-CH-0278:
Dyadic Interactions in Depressed and Non-Depressed Mothers with Their Infants

* 02-CH-0100:
Supplemental Calcium in Overweight Out-Patients

* 02-CC-0044:
Morbidity Following the Diagnosis and Treatment of Patients with Breast Cancer: A Multi-Institutional Study Between the National Institutes of Health (NIH) Rehabilitation Medicine Department (RMD) and the National Naval Medical Center (NNMC) Breast Care

* 02-C-0268:
Prospective Study of Risk-Reducing Salpingo-Oophorectomy and Longitudinal CA-125 Screening Among Women at Increased Genetic Risk of Ovarian Cancer

* 02-C-0241:
A Phase I Trial of UCN-01 and Prednisone in Patients with Refractory Solid Tumors and Lymphomas

* 02-C-0215:
Amifostine as a Rectal Protector During External Beam Radiotherapy for Prostate Cancer: A Phase II Study

* 02-C-0207:
A Phase II Study of MR-Guided High Dose Rate Brachytherapy Boosts For Prostate Cancer

* 02-C-0204:
Survey of Patients' Motivations, Perceptions, and Expectations in Phase I Clinical Trials

* 02-C-0141:
Phase I Trial and Pharmacokinetic Study of ABT-751, An Orally Bioavailable Tubulin Binding Agent, on a 7 Day and 21 Day Dosing Schedule in Pediatric Patients With Refractory Solid Tumors

* 02-C-0083:
A Multidose Phase I Study of Oral CC5013, a Thalidomide Derivative, in Patients with Refractory Metastatic Cancer

* 02-AT-0260:
A Phase I Study of the Effect of Mistletoe Extract, a Complementary, Medicine Botanical, on Pharmacokinetics, Pharmacodynamics and Safety of Gemcitabine in Patients with Advanced Solid Tumors

* 02-AR-0272:
A Phase I, Open-Labeled, Dose-Ascending Clinical Trial of Immunotherapy of MRA, A Humanized Anti-IL 6 Receptor Monoclonal Antibody, In Patients with Systemic Lupus Erythematosus

* 02-AR-0156:
A Randomized, Double-Blind, Placebo-Controlled Trial of Infliximab In Patients With Dermatomyositis and Polymyositis

* 01-I-0171:
Substudies of ESPRIT: ESPRIT Influenza Vaccine Substudy (FLUVAC) and ESPRIT Tetanus-Pneumococcal Vaccine Substudy (TEPVAC)

* 01-I-0126:
A Phase III Multicenter Randomized Study of the Biological and Clinical Efficacy of Subcutaneous Recombinant, Human Interleukin-2 in HIV-Infected Patients with Low CD4+ Counts Under Active Antiretroviral Therapy (SILCAAT Amendment 4)

* 01-HG-0095:
Mutation Detection for Lowe Syndrome

* 01-H-0223:
Inhaled Nitric Oxide and Transfusion Therapy for Patients with Sickle Cell Anemia and Secondary Pulmonary Hypertension

* 01-H-0162:
Ex Vivo Selective Depletion of Alloreactive Donor T-Lymphocytes Utilizing RFT5-SMPT-dgA, a Specific Anti-Interleukin-2 Receptor Immunotoxin: Reducing GVHD Risk Associated with HLA-Matched, Nonmyeloablative, Peripheral Blood Stem Cell Transplantation for

* 01-H-0031:
National Heart, Lung, and Blood Institute Data Distribution

* 01-DK-0249:
Ingested Interferon-Alpha: Prolongation or Permanence of the "Honeymoon" Phase in Newly Diagnosed Diabetes Mellitus

* 01-DK-0246:
Combination of Lamivudine and Adefovir Dipivoxil for Treatment of Chronic Hepatitis B

* 01-DK-0036:
Solitary Islet Transplantation for Type 1 Diabetes Mellitus Using Steroid Sparing Immunosuppression

* 01-CH-0096:
Catecholamine Reserve and Exercise Tolerance in Subjects with Congenital Adrenal Hyperplasia and in Healthy Controls

* 01-C-0236:
Follow-Up of a Phase-I Gene Therapy Trial of Patients with Leukocyte Adherence Deficiency

* 01-C-0235:
Combination Antibody Therapy with Apolizumab (1D10) and Rituximab (CD20) in Relapsed Lymphoma and CLL

* 01-C-0222:
A Phase II Randomized, Cross-Over, Double-Blinded, Placebo-Controlled Trial of the Farnesyltransferase Inhibitor R115777 in Pediatric Patients with Neurofibromatosis Type I and Progressive Plexiform Neurofibromas

* 01-C-0173:
A Pilot Study to Evaluate Angiogenesis after Treatment with Bevacizumab (Anti-VEGF Humanized Monoclonal Antibody) in Previously Untreated Patients with Inflammatory Breast Cancer or Locally Advanced Breast Cancer

* 01-C-0124:
A Phase I Study of an Oral Histone Deacetylase Inhibitor, MS-275, in Refractory Solid Tumors and Lymphomas

* 01-C-0091:
Phase I Trial and Pharmacokinetic Study of Tariquidar (XR9576), a P-Glycoprotein Inhibitor, in Combination with Doxorubicin, Vinorelbine or Docetaxel in Pediatric Patients with Refractory Solid Tumors Including Brain Tumors

* 01-C-0049:
Phase II Trial of Depsipeptide in Patients with Cutaneous T-Cell Lymphoma and Relapsed Peripheral T-Cell Lymphoma

* 01-C-0037:
Late Effects of Treatment in Survivors of Pediatric Sarcomas

* 01-C-0027:
Natural History of Plexiform in Neurofibromatosis Type I

* 01-C-0009:
Breast Imaging Screening Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-up Study

* 01-C-0008:
Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Menstrual Cycle Pilot Study

* 01-AA-0141:
Polyunsaturated Fatty Acids and the Neurochemistry of Cardiovascular and Behavioral Responses in Aggressive Alcoholics

* 01-AA-0098:
The Effect of Fluoxetine on Measures of Domestic Violence

* 00-N-0140:
A Prospective Natural History Study of VHL Patients with CNS Hemangioblastomas

* 00-I-0163:
Persistence of Epstein-Barr Virus in Vivo

* 00-I-0143:
Chemokine System Polymorphisms and Risk of Atherosclerosis (CAD)

* 00-I-0110:
Analysis of HIV Genetic Variation in Patients Prior to Initiation of Highly Active Antiretroviral Therapy

* 00-I-0071:
Randomized, Open-Label, Phase III, International Study of Recombinant IL-2 (Proleukin) in Pts. w/HIV-1 Infection and CD4 Cell Counts Greater than or Equal to 300 Cells/mm3: Eval of Subcutaneous Proleukin in Randomized International Trial (ESPIRIT)

* 00-HG-0223:
Decisions of Female Adolescents about Carrier Testing in Families with X-Linked Severe Combined Immunodeficiency (XSCID)

* 00-HG-0191:
Clinical, Molecular and Biochemical Characterization of Familial Encephalopathy with Neuroserpin Inclusion Bodies

* 00-H-0169:
A Phase II Study of Antithymocyte Globulin (ATG) and Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)

* 00-H-0032:
Treatment of Severe Aplastic Anemia with Combined Immunosuppression: Antithymocyte Globulin (ATG) and Cyclosporine A (CSA), and Mycophenolate Mofetil (MMF)

* 00-DK-0196:
Sirolimus Monotherapy to Optimize Activation Induced Cell Death (AICD) in Renal Transplants Following Lymphocyte Depletion Induction with Thymoglobulin

* 00-DK-0186:
The Hep C Antiviral Long-Term Tx Against Cirrhosis (HALT-C) Trial: A Randomized Controlled Trial to Evaluate the Safety & Efficacy of Long-Term Peginterferon Alpha2A for Tx of Chronic Hep C in Patients Who Failed to Respond to Previous Interferon Therap

* 00-DK-0042:
Pirfenidone in Focal Segmental Glomerulosclerosis:Phase II Study

* 00-D-0183:
Effects of the Aromatase Inhibitor Letrozole on Pubertal Progression and Indices of Bone Turnover in Girls with Precocious Puberty and McCune-Albright Syndrome (MAS)

* 00-CH-0134:
Effects of Metformin on Energy Intake, Energy Expenditure, and Body Weight in Overweight Children with Insulin Resistance

* 00-C-0201:
Active Immunization of Sibling Stem Cell Transplant Donors against Purified Myeloma Protein of the Stem Cell Recipient with Multiple Myeloma in the Setting of Non-Myeloablative, HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation

* 00-C-0193:
A Study of the Effects of Potent Anti-HIV Therapy on Parameters Hypothesized to Be Related to the Pathogenesis of Kaposi's Sarcoma (KS) in HIV-Infected Individuals

* 00-C-0133:
Pilot Study of Idiotype Vaccine and EPOCH-Rituximab Chemotherapy in Untreated Mantle Cell Lymphoma

* 00-C-0092:
A Randomized Trial of Filgrastim-SD/01 vs. Filgrastim in Newly Diagnosed Children and Young Adults with Sarcoma Treated with Dose-Intensive Chemotherapy

* 00-C-0080:
A Double Blind Randomized Crossover Phase III Study of Oral Thalidomide versus Placebo in Patients with Stage D0 Androgen Dependent Prostate Cancer Following Limited Hormonal Ablation

* 00-C-0079:
Susceptibility to Breast Cancer

* 00-C-0018:
A Pilot Study of Proteomic Evaluation of Epithelial Ovarian Cancer Patients in First Clinical Remission: Development of a Protein Fingerprint Profile Associated with Relapse

* 99-N-0169:
Effect of the Humanized Monoclonal Antibody Against the Interleukin-2 Receptor Alpha Subunit (IL-2R-Alpha; Zenapax® (Registered Trademark)) on Inflammatory Activity in the CNS in MS in a Baseline-to-Treatment, Cross-Over, MRI-Controlled Single Cente

* 99-M-0166:
Investigation of Brain Function During Eyeblink Responding in Normal Volunteers and Patients with Schizophrenia (A Study of Behavior and Evoked Potentials)

* 99-I-0149:
Analysis of the Occurrence of Perilesional Edema and Seizures in Patients With Inactive Cysticercosis

* 99-I-0106:
Trial of Varicella Vaccine for the Prevention of Herpes Zoster and Its Complications

* 99-I-0015:
Immunologic and Virologic Characterization of HIV-Infected Patients After Cessation of Highly Active Antiretroviral Therapy (HAART)

* 99-HG-0056:
Pulmonary Fibrosis Associated with Rheumatoid Arthritis: Definition of the Natural History of Disease

* 99-H-0048:
Technical Evaluation of Cardiovascular Magnetic Resonance Imaging and Spectroscopy

* 99-H-0046:
Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T-Cell Add-Back for Hematological Malignancies - Role of Cyclosporine

* 99-DK-0120:
Screening Protocol for Patients Needing a Kidney, Kidney-Pancreas, or Islet Cell Transplant

* 99-DK-0107:
Live Donor Renal Donation for Allotransplantation

* 99-D-0003:
Evaluation and Treatment to Improve Bone Quality and Prevent Fractures by the Percutaneous Replacement of Diseased Tissue in Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome

* 99-C-0143:
Pilot Study of Donor Th2 Cells for the Prevention of Graft-Versus-Host Disease in the Setting of Non-myeloablative, HLA-matched Allogeneic Peripheral Blood Stem Cell Transplantation

* 99-C-0137:
Vaccine Therapy with Tumor Specific p53 Peptides in Adult Patients with Low Burden Adenocarcinoma of the Ovary

* 99-C-0125:
Osteosarcoma: Outcome of Therapy Based on Histologic Response: A Collaborative Effort of the POB/NCI, Texas Children's Hospital and University of Oklahoma

* 99-C-0102:
A Phase II Trial of Oral Thalidomide as an Adjuvant Agent Following Metastasectomy in Patients with Recurrent Colorectal Cancer

* 99-C-0088:
(1)H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients who Receive Neurotoxic Therapy

* 99-C-0081:
Methods in Education for Breast Cancer Genetics

* 99-C-0053:
Von Hippel-Lindau Disease Genetic Epidemiology Study

* 98-D-0146:
A Randomized, Placebo-Controlled Trial of Alendronate in the Treatment of Polyostotic Fibrous Dysplasia and the McCune-Albright Syndrome

* 98-CH-0111:
Safety and Efficacy of Orlistat (Xenical, Hoffmann LaRoche) in African American and Caucasian Children and Adolescents with Obesity-Related Comorbid Conditions

* 98-C-0139:
Vaccine Therapy with Tumor Specific Mutated VHL Peptides in Adult Cancer Patients with Renal Cell Carcinoma

* 98-C-0138:
Evaluation of the Association of Polymorphisms in the Innate Immune System with the Risk for Blastomycosis Dermatitidis Infection in Patients not Infected with HIV and Complications Associated with Blastomycosis dermatitidis Infection

* 98-C-0137:
Evaluation of the Association of Polymorphisms in the Innate Immune System with the Risk for Cryptococcus neoformans Infection in Patients not Infected with HIV and Complications Associated with Cryptococcus neoformans Infection

* 98-AR-0124:
Genetics of Rheumatoid Arthritis: The North American Rheumatoid Arthritis Consortium

* 97-N-0170:
The Nosology and Etiology of Leukodystrophies of Unknown Cause

* 97-M-0126:
Childhood Onset Psychotic Disorders: Characterization and Treatment with Atypical Neuroleptics

* 97-I-0189:
Studies of Lymphocyte Kinetics Using Bromodeoxyuridine

* 97-I-0166:
Polymorphism of the Herpes Simplex Virus Receptor

* 97-I-0082:
Use of Combination Antiviral Therapy to Delineate the Identity and Longevity of Persistent Reservoirs of HIV-1 Infection and Replication

* 97-HG-0173:
Gene Analysis in Parkinson's Disease

* 97-HG-0078:
Genetic Analysis of Parkinson's Disease

* 97-H-0204:
Cardiovascular Magnetic Resonance Imaging

* 97-H-0202:
Low Intensity Preparative Regimen Followed by HLA-Matched, Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematologic Malignancies in Older Adults

* 97-H-0130:
Collection of Blood and Bone Marrow from Normal Volunteers and Patients for Research Purposes

* 97-H-0117:
A Randomized Trial of Antithymocyte Globulin and Cyclosporine versus Cyclophosphamide and Cyclosporine in the Treatment of Severe Aplastic Anemia

* 97-H-0099:
HLA-Matched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies

* 97-H-0026:
Magnetic Resonance at 1.5 and 3 Tesla

* 97-C-0077:
Vaccination of Follicular Lymphomas with Tumor-Derived Immunoglobulin Idiotype

* 97-C-0052:
A Pilot Study of Autologous T-Cell Transplantation with Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas

* 97-C-0050:
A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 with or without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas

* 97-C-0040:
EPOCH Chemotherapy Plus Rituximab for Previously Treated Patients with AIDS-Associated Lymphoma

* 96-CH-0033:
An Open, Randomized, Long-Term Clinical Trial of Flutamide, Testolactone, and Reduced Hydrocortisone Dose vs. Conventional Treatment of Children with Congenital Adrenal Hyperplasia

* 96-C-0133:
Active Specific Immunotherapy for Follicular Lymphomas with Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines

* 96-C-0104:
A Multi-Center Study of Paclitaxel/Cyclophosphamide and High Dose Melphalan/Etoposide with Autologous Progenitor Cell Transplantation for the Treatment of Inflammatory Breast Cancer

* 95-I-0134:
Gene Therapy Approach for Chronic Granulomatous Disease

* 95-H-0167:
Effect of Hypoxia and Smoking on Oxidation of Proteins and Nucleic Acids in Human Volunteers

* 95-CH-0104:
Internal Jugular Vein Sampling for ACTH Levels for the Differential Diagnosis of Cushing Syndrome

* 95-C-0055:
A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin with G-CSF for Patients with Newly Diagnosed Advanced Stage Ovarian Cancer

* 94-I-0203:
Cytokine Expression in Allergic Asthma

* 94-H-0033:
Retroviral Mediated Gene Transfer of the Fanconi Anemia Complementation Group C Gene to Hematopoietic Progenitors of Group C Patients

* 92-N-0246:
Gene Therapy for the Treatment of Brain Tumors Using Intra-Tumoral Transduction with the Thymidine Kinase Gene and Intravenous Ganciclovir

* 92-DK-0033:
Pharmacokinetics and Biodistribution of Ascorbic Acid in Healthy Human Subjects

* 92-CC-0141:
The Cardiopulmonary Effects of Endotoxin in Normal Human Volunteers

* 90-DK-0137:
Evaluation of the Gastrinoma in Patients with Zollinger-Ellison Syndrome

* 85-M-0115:
Biological Markers in Childhood Psychiatric Disorders

* 85-H-0105:
Cardiovascular Evaluation of Homozygous Familial Hypercholesterolemia

* 85-H-0087:
Clinical Course of Patients with Transfusional Hemochromatosis on Deferoxamine

* 84-H-0029:
Effect of Hydroxyurea on Fetal Hemoglobin Synthesis in Patients with Sickle Cell Anemia

* 79-C-0111:
The Treatment of Stage I and II Carcinoma of the Breast with Mastectomy and Axillary Dissection vs. Excisional Biopsy, Axillary Dissection, and Definitive Irradiation

* 76-DK-0081:
Studies with 1,25-Dihydroxycholecalciferol

Command Menu Bar

Search The Studies | Help | Questions |
Clinical Center Home | NIH Home


Clinical Center LogoNational Institutes of Health Clinical Center
Bethesda, Maryland 20892. Last update: 09/15/2008

Search The Studies Help Questions
Search The Studies Help Questions